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A B S T R A C T
Background
Overweight and obesity are increasing worldwide and are considered to be a major public health issue of the 21st century. Introducing
taxation of the fat content in foods is considered a potentially powerful policy tool to reduce consumption of foods high in fat or saturated
fat, or both.
Objectives
To assess the eIects of taxation of the fat content in food on consumption of total fat and saturated fat, energy intake, overweight, obesity,
and other adverse health outcomes in the general population.
Search methods
We searched CENTRAL, Cochrane Database of Systematic Reviews, MEDLINE, Embase, and 15 other databases and trial registers on 12
September 2019. We handsearched the reference lists of all records of included studies, searched websites of international organizations
and institutions (14 October 2019), and contacted review advisory group members to identify planned, ongoing, or unpublished studies
(26 February 2020).
Selection criteria
In line with Cochrane EIective Practice and Organisation of Care Group (EPOC) criteria, we included the following study types: randomized
controlled trials (RCTs), cluster-randomized controlled trials (cRCTs), non-randomized controlled trials (nRCTs), controlled before-aLer
(CBA) studies, and interrupted time series studies. We included studies that evaluated the eIects of taxes on the fat content in foods.
Such a tax could be expressed as sales, excise, or special value added tax (VAT) on the final product or an intermediary product. Eligible
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interventions were taxation at any level, with no restriction on the duration or the implementation level (i.e. local, regional, national, or
multinational). Eligible study populations were children (zero to 17 years) and adults (18 years or older) from any country and setting. We
excluded studies that focused on specific subgroups only (e.g. people receiving pharmaceutical intervention; people undergoing a surgical
intervention; ill people who are overweight or obese as a side eIect, such as those with thyroiditis and depression; and people with chronic
illness). Primary outcomes were total fat consumption, consumption of saturated fat, energy intake through fat, energy intake through
saturated fat, total energy intake, and incidence/prevalence of overweight or obesity. We did not exclude studies based on country, setting,
comparison, or population.
Data collection and analysis
We used standard Cochrane methods for all phases of the review. Risk of bias of the included studies was assessed using the criteria of
Cochrane’s ‘Risk of bias’ tool and the EPOC Group’s guidance. Results of the review are summarized narratively and the certainty of the
evidence was assessed using the GRADE approach. These steps were done by two review authors, independently.
Main results
We identified 23,281 records from searching electronic databases and 1173 records from other sources, leading to a total of 24,454 records.
Two studies met the criteria for inclusion in the review. Both included studies investigated the eIect the Danish tax on saturated fat
contained in selected food items between 2011 and 2012. Both studies used an interrupted time series design. Neither included study
had a parallel control group from another geographic area. The included studies investigated an unbalanced panel of approximately 2000
households in Denmark and the sales data from a specific Danish supermarket chain (1293 stores). Therefore, the included studies did
not address individual participants, and no restriction regarding age, sex, and socioeconomic characteristics were defined. We judged the
overall risk of bias of the two included studies as unclear.
For the outcome total consumption of fat, a reduction of 41.8 grams per week per person in a household (P < 0.001) was estimated. For the
consumption of saturated fat, one study reported a reduction of 4.2% from minced beef sales, a reduction of 5.8% from cream sales, and
an increase of 0.5% to sour cream sales (no measures of statistical precision were reported for these estimates). These estimates are based
on a restricted number of food types and derived from sales data; they do not measure individual intake. Moreover, these estimates do
not account for other relevant sources of fat intake (e.g. packaged or processed food) or other food outlets (e.g. restaurants or cafeterias);
hence, we judged the evidence on the eIect of taxation on total fat consumption or saturated fat consumption to be very uncertain. We
did not identify evidence on the eIect of the intervention on energy intake or the incidence or prevalence of overweight or obesity.
Authors' conclusions
Given the very low quality of the evidence currently available, we are unable to reliably establish whether a tax on total fat or saturated
fat is eIective or ineIective in reducing consumption of total fat or saturated fat. There is currently no evidence on the eIect of a tax on
total fat or saturated fat on total energy intake or energy intake through saturated fat or total fat, or preventing the incidence or reducing
the prevalence of overweight or obesity.
P L A I N   L A N G U A G E   S U M M A R Y
Does a tax on the fat content of foods reduce obesity and help people to eat less fat and less saturated fat?
What is obesity?
Body mass index (BMI) is usually a useful measure to show whether people are a healthy weight for their height. A BMI of 18 to 25 shows
a healthy weight, a BMI over 25 is considered overweight, and a BMI over 30 shows obesity.
Obesity is generally caused by consuming more energy (calories) than you burn oI through physical activity or exercise. The body stores
the excess energy as fat.
Obesity can lead to serious and life-threatening conditions, including type 2 diabetes, coronary heart disease, some types of cancer, and
stroke. Obesity can also aIect people's quality of life (well-being).
What are fats?
Fat is essential to a healthy, balanced diet. Fats help the body to absorb some vitamins, and are a source of some fatty acids that the body
cannot make. The main types of fat in foods are:
- saturated (mostly from animal products, such as meat, cow's milk, cheese, cream, and butter); and
- unsaturated (mostly found in oils from plants and fish).
Health guidelines usually recommend that people should:
- reduce the overall amount of fat they eat;
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- limit the amount of saturated fats they eat; and
- eat unsaturated fats instead of saturated fats.
Why we did this Cochrane Review
Rates of overweight and obesity are increasing around the world and are a major public health issue. We wanted to know whether
increasing the prices of foods that have a lot of fats or saturated fats could put people oI eating them, and reduce obesity.
What did we do?
We searched for studies that looked at the eIects of a tax on the fat content of foods. We were interested in how a tax aIected the:
- total amount of fat, and saturated fats eaten;
- total calories eaten;
- calories eaten from all fats and saturated fats; and
- rates of overweight and obesity.
Search date: we included evidence published up to September 2019.
What we found
We found two studies from Denmark, conducted during 2011 to 2012. One looked at how a tax on some high-fat foods aIected household
demand for them; the other looked at information on supermarket sales for certain high-fat foods (minced beef, cream, and sour cream).
They compared their results with data from before the tax started.
Both studies looked at a small number of foods that people bought, but not what foods people ate. They didn't measure how much total
fat or saturated fat were eaten.
What are the results of our review?
If the amount of foods bought reflected the amount of foods eaten, then taxing the fat content of certain foods:
- might reduce the total amount of fats eaten by 41.8 grams a week for each person in a household, in one study of 2000 households; and
- might reduce the amount of saturated fats eaten (in minced beef and cream), in one study of 1293 supermarkets.
No studies measured the eIect of taxing the fat content of foods on calories eaten, on obesity or overweight, or on total food sales.
How reliable are these results?
We are not confident in the results because the evidence is only from two studies; and these studies only measured a small number of
foods bought, and did not measure foods eaten. One study did not report statistics about the accuracy of its results.
The results were from observational studies, in which researchers observe the eIect of a factor (such as taxation) without trying to change
who does, or does not, experience it. Observational studies do not give as reliable evidence as randomized controlled studies, in which
the treatments people receive are decided at random.
Conclusions
We did not find enough reliable evidence to find out whether a tax on the fat content of foods resulted in people eating less fat, or less
saturated fat.
We did not find any evidence about how a tax on the fat content of foods aIected obesity or overweight.
The results of our review will change when further evidence becomes available.
Taxation of the fat content of foods for reducing their consumption and preventing obesity or other adverse health outcomes (Review)
Copyright © 2020 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The Cochrane
Collaboration.
3
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
S U M M A R Y   O F   F I N D I N G S
 
Summary of findings 1.   Taxation of the fat content of foods compared to no taxation for reducing their
consumption and preventing obesity or other adverse health outcomes
Taxation of the fat content of foods compared to no taxation for reducing their consumption and preventing obesity or other
adverse health outcomes
Patient or population: general population of Denmark
Setting: Denmark
Intervention: taxation of the fat content of foods
Comparison: no taxation
Outcomes № of participants
(studies)
Follow up
Certainty of
the evidence
(GRADE)
Impact
Total fat con-
sumption
2000 households (ITS
design)
(1 observational
study)
⊕⊝⊝⊝
VERY LOW 1 2
There is very uncertain evidence that taxing the fat content of foods
reduces estimated total fat consumption by 41.8 grams per week, per
person in a household (P < 0.001).
Total saturated
fat consump-
tion
1293 supermarkets
(ITS design)
(1 observational
study)
⊕⊝⊝⊝
VERY LOW 1 2 3
There is very uncertain evidence that taxing the fat content of foods
reduces the estimated saturated fat content of sales by 4.2% for
minced beef and by 5.8% for cream, and increases the estimated sat-
urated fat content of sales by 0.5% for sour cream. (No measure of
statistical precision was reported for any of these results.)
Energy intake See comment 0 (0) Not reported4
Overweight See comment 0 (0) Not reported4
Obesity See comment 0 (0) Not reported4
Total sales See comment 0 (0) Not reported4
ITS: interrupted time series
GRADE Working Group grades of evidence
High certainty: we are very confident that the true effect lies close to that of the estimate of the effect
Moderate certainty: we are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the ef-
fect, but there is a possibility that it is substantially different
Low certainty: our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the
effect
Very low certainty: we have very little confidence in the effect estimate: The true effect is likely to be substantially different from the
estimate of effect
1 Observational studies with an ITS design start out at the level 'low-certainty'.
2 Downgraded 2 levels because of indirectness (calculation of eIect estimates were based on a restricted number of food items and sales/
purchases of food items was used as a proxy to measure consumption).
3 Downgraded 2 levels because of imprecision (study did not report confidence intervals, P values or any other measure about the statistical
precision of the eIect estimates).
4 No study measured the eIects of taxing fat content of food on energy intake, overweight, obesity, or total sales.
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B A C K G R O U N D
Description of the condition
Overweight and obesity (a body mass index (BMI) of 25 or more
and 30 or more, respectively) are increasing worldwide and present
a major public health issue of the 21st century (NCD-RisC 2016;
WHO 2014; Swinburn 2019). The Global Burden of Disease Study
estimated that the prevalence of obesity more than doubled
between 1980 and 2017 (GBD 2017). In 2016, approximately 2 billion
adults were overweight, and of these over 650 million were obese;
that is, 39% of adults aged 18 years and over were overweight in
2016, and 13% were obese. Similarly, approximately 340 million
children and adolescents aged five to 19 were overweight or
obese in 2016, and 40 million children under the age of five were
overweight or obese in 2018 (WHO 2020). Although the increase
of adult obesity has stabilized (albeit at very high levels) in some
high-income countries (HICs), the prevalence of obesity in low- and
middle-income countries (LMICs) and several HICs is continuing
to rise (Ng 2014; Wells 2020). The reasons for these trends are
complex and influenced by a broad variety of social determinants
of health, such as urbanization, changes in types of employment,
and alterations to the food supply (Lang 2009). In LMICs the rise
has been partly attributed to economic modernization and lifestyle
changes, i.e. a transition to a 'Western diet' that is broadly defined
by a high intake of refined carbohydrates, added sugars, fats, and
animal-source foods (Goryakin 2015; Popkin 2012).
Obesity is a major risk factor for mortality and morbidity
(Lhachimi 2013). In 2015, excessive body weight was estimated
to cause 4 million deaths and accounted for a loss of 120 million
disability-adjusted life years (Swinburn 2019). In particular, non-
communicable diseases, such as type 2 diabetes, cardiovascular
diseases, certain cancers, and musculoskeletal disorders, are
potential health consequences of a raised BMI (Barber 2018; Guh
2009). This also makes obesity a significant factor for disability
(Lhachimi 2016). Non-communicable diseases are already the
leading cause of death in HICs, and are increasing in LMICs (WHO
2014). Moreover, the increased prevalence of chronic diseases in
regions where individuals have insuIicient access to appropriate
health care may exacerbate the harmful consequences of obesity
on morbidity and mortality for those populations. For example,
if an obese person with type 2 diabetes does not have regular
access to insulin, this may result in particularly premature death,
disability, or morbidity (Seidell 2015; Wells 2020).
Overweight and obesity are oLen defined as the "abnormal or
excessive body fat accumulation in adipose tissue" (WHO 2000;
WHO 2011). At the individual level, overweight and obesity are
mainly caused by an imbalance in energy intake and energy
expenditure. In the 2014 Declaration of Rome on Nutrition, the
member states of the Food and Agriculture Organization (FAO)
and the World Health Organization (WHO) noted certain aspects
of a diet that increase the susceptibility to both overweight and
obesity, as well as comorbid non-communicable diseases; chief
among these was consumption of food that is high in fat (FAO/
WHO 2015). Fats are energy dense (i.e. 37 kilojoules (kJ) or 9
kilocalories(kcal) per gram), which contributes to the palatability
of food and enables absorption of fat-soluble vitamins. Moreover,
fats are crucial for development and survival during the early
stages of life, i.e. embryonic development, early growth aLer birth,
and childhood (Burlingame 2009). Excess fat intake, however, is
associated with the rise in obesity. The consumption of particular
types of fat has been linked to a range of diseases and adverse
health outcomes, such as type 2 diabetes, coronary heart disease,
stroke, and certain types of cancer (FAO 2010; Huang 2019; Wells
2020).
Dietary fats are conventionally grouped into three broad categories
based on the number of double bonds the molecules exhibit, i.e.
(1) saturated fatty acids, (2) monounsaturated fatty acids, and (3)
polyunsaturated fatty acids. Saturated fats are acids with only
single bonds between adjacent carbon atoms, i.e. every carbon
atom carries its full quota of hydrogen atoms (Bender 2014). The
most notable dietary sources of saturated fats are animal products
such as meat, cow's milk, eggs, butter, and salmon. Plant products,
such as palm oil, coconut, and chocolate/cocoa butter, are also
substantial sources of dietary saturated fat intake (Souza 2015).
Unsaturated fatty acids have one or more double bonds between
carbon atoms: monounsaturated fatty acids have only one of those
double bonds whereas polyunsaturated fatty acids have two or
more. Monounsaturated fatty acids can be found in animal and
vegetable products such as red meat, dairy products, and high-fat
fruits. Many polyunsaturated fatty acids can be found in most fats,
whereas certain nutritionally-important subtypes are mostly found
in oily fish such as salmon or herring (FAO 2010).
Several authoritative dietary guidelines recommend that total fat
intake should contribute less than 30% of daily energy intake
in adults, and that saturated fats should be limited to less than
10% of total energy intake (Eckel 2014; FAO 2010; FAO/WHO
2015; Lichtenstein 2006; NDA 2010; US Department of Agriculture
2010; WHO 2018). Hence, when reducing the total fat intake, the
share of saturated fat might be lowered respectively. A systematic
review (Harika 2013), however, reported that in the majority of the
countries for which data were available (28 out of 45 countries),
average total fat intake was above the recommended 30% energy
threshold. The average proportion of energy contributed by total
fats ranged from 11.1% (in Bangladesh) to 46.2% (in Greece).
Moreover, for 29 countries the average saturated fat intake was
larger than the recommended 10% of total energy intake, ranging
from 2.9% (in Bangladesh) to 20.9% (in Indonesia). Only a few of
the included studies reported data on the distribution of fat intake
within a population. Notably, the share of the population with an
intake above the recommended threshold varied widely between
countries (e.g. approximately 95% of the Danish population has a
saturated fat intake of more than 10% energy, versus only 17% of
the Indian population). In particular, for LMICs the share of total
fat and saturated fat intake is predicted to increase as countries
develop economically and socially and, therefore, an increased
intake will become a component of diets across the globe (Popkin
2020; Popkin 2012; Wolmarans 2009).
Fat consumption and preventing obesity or other
adverse health outcomes
The role of dietary fat intake in the worldwide rise in obesity is
heavily debated. In particular, two major issues emerge (Bray 1998):
(1) whether a decrease in overall fat intake can lead to a decrease of
overweight and obesity, and (2) whether the increase of overweight
and obesity in LMICs can be halted or slowed by preventing
the progression towards a higher-fat diet. A Cochrane Review
(commissioned by the WHO Nutrition Guidance Expert Advisory
Group (NUGAG) as part of the process of updating the guidelines
on fat intake) investigated the relationship between total fat intake
and obesity (Hooper 2015b). This review excluded studies that
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recruited populations specifically for weight loss and interventions
intended to result in weight loss. Such studies are likely to be
confounded by the implicit aim of reducing calorie intake, and
therefore may over-represent studies with obese populations from
Western countries. This would limit the transferability to non-
obese populations or countries. Based on a meta-analysis of the
included RCTs, the review authors concluded that consuming a
lower proportion of total energy from fat results in small reductions
in body weight and BMI among adults. Moreover, there was no
suggestion of harms that might mitigate any benefits of weight loss.
These findings were confirmed in a recent update of the review
(Hooper 2020).
The authors recommend that for populations where the mean
total fat intake is below 30% of energy consumed, such as in
many LMICs, staying below this threshold may help to avoid
obesity. For populations where mean total fat intake is above
the 30% energy threshold, a reduction in intake below this
threshold may support the maintenance of healthy weight (Hooper
2015b). The consumption of saturated fat has long been suspected
to increase the risk and incidence of coronary heart disease
(Keys 1950). However, the precise relationship is still being
debated. A related Cochrane Review investigated the relationship
between saturated fat intake and cardiovascular disease (Hooper
2015a), and identified a robust eIect on reducing combined
cardiovascular events but not a general eIect on all-cause mortality
or cardiovascular mortality. Regarding the association between the
intake of saturated fat and type 2 diabetes, a FAO expert group
from their review of the literature concluded that there is a possible
positive relationship (FAO 2010), however a review solely based on
observational studies did not identify such an association (Souza
2015).
One recommended alternative to reducing the total fat content
of foods by lowering the total amount of saturated fat in them,
is replacing saturated fat with polyunsaturated fat, as some of
the latter fats may have a beneficial health eIect. Saturated
fats are most commonly found in processed or energy-dense,
nutrient-poor food. The Cochrane Review suggests that replacing
saturated fat with polyunsaturated fat leads to a reduction in
cardiovascular events (27% less), but this is not the case for
other types of replacement (e.g. with carbohydrates, protein,
or monounsaturated fats) (Hooper 2015a). Similarly, a Cochrane
Review investigating the eIect of increasing or decreasing amounts
of a certain type of polyunsaturated fat (Omega 6) did not find
evidence of any beneficial or harmful eIects (Al-Khudairy 2015).
Therefore, reducing the share of total energy coming from fat will
have beneficial eIects, while current evidence suggests that this
should be predominantly achieved through a reduction in the
content of saturated fat.
Description of the intervention
Taxation as a fiscal measure is usually designed to raise revenue
for government expenditure. Taxation on commodities, however,
has also been used to influence consumer behaviour, e.g. taxation
of foreign goods to discourage imports by making them more
expensive and, hence, protecting domestic producers. Similarly,
taxation has been used to generally disincentivize consumption
(and production). For example, many countries are considering
or already have introduced 'sin taxes' on alcohol and tobacco
to prevent alcohol and tobacco use, oLen with the primary aim
of preventing or reducing resultant public health harms (Blecher
2015). The WHO Commission on Social Determinants of Health
has recommended taxation as a policy tool for addressing the
social determinants of health to improve health equity (CSHD
2008). Fat taxes can be classified as an intersectoral socioeconomic
intervention on the social determinants of health to improve health
equity (Pega 2017).
Current evidence on the health eIects of the diIerent types of
dietary fats - as outlined above, and reflected in several dietary
guidelines (Eckel 2014; FAO 2010; FAO/WHO 2015; Lichtenstein
2006; NDA 2010; US Department of Agriculture 2010) - suggests
that a tax on fat content should be designed in such a way that
it may reduce the overall fat content by replacing unhealthy fats,
e.g. saturated fat (WHO 2018; Schonbach 2019). In this Cochrane
review, we included all types of taxation targeting fat contents in
general but we paid special attention to if, and how, less desirable
dietary fats (in particular saturated fats) were being aIected by the
intervention.
Taxation to curb the content of fat in food is usually achieved
through indirect taxes, implemented either as a sales or an excise
tax (Sassi 2010). While producers or sellers pay the tax to the
government, they are usually expected to shiL the tax burden to
the consumer by raising the price of the item in question. A sales
tax is usually added to the price of a product at the point of sale.
Value added tax (VAT; a special form of sales tax that is very common
in many European countries) avoids a taxation cascade when a
product has to go through a number of intermediaries by only
taxing the value added by a producer/reseller, i.e. value added
equals sales price minus prices for input. The level of a sales tax
can diIer by type of commodity. For example, the UK has three
diIerent rates of VAT: standard (20%), reduced (5%), zero (no tax).
Introducing a (higher) tax on a targeted product, e.g. foods high
in saturated fat, may only require reassigning the product to a
diIerent category (Mytton 2007). A disadvantage of sales taxes/VAT,
however, is that the tax is on the price and not on the volume of the
product (Bonnet 2013). As larger volumes of a product are usually
cheaper in relative terms than smaller volumes, the impact of a
sales tax could be reduced by increasing package size. Excise taxes,
on the other hand, are usually levied as a fixed rate per unit-volume
of content, independent of price or value. Hence, an excise tax may
have more potential to reduce the incentives for consumers to buy
larger volumes of the taxed product, or switch to cheaper brands
with virtually identical fat content.
How the intervention might work
Standard economic theory predicts that a price increase leads
to a reduction in consumption. This finding, measured through
elasticities, has been well established, not least for health-
relevant commodities such as tobacco and alcohol (Lhachimi 2012;
Schonbach 2019a). However, it is not always clear to what extent
a tax will eventually increase retail prices. Although indirect taxes
are assumed to be shiLed to the consumer, examples exist where
producers and retailers avoided doing this fully, illustrated by calls
for minimum unit pricing of alcohol as a complement to taxation
(Katikireddi 2014). In addition to increasing prices paid by the
consumer as a consequence of the tax, producers may broadly
respond in two ways. First, taxing (excessive saturated) fat content
may lead to altered production processes, resulting in lower
saturated fat content in absolute terms, and thereby also reducing
total fat content of a food product and the overall calorie content of
a product. Second, producers may replace the share of saturated fat
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with other fats or nutrients, or both. Hence, the new calorie content
may now be higher, lower, or unchanged. Moreover, these new
ingredients may or may not have further health implications of their
own. The first case is in line with the intention of such a tax and is
expected to have overall beneficial health outcomes. In the second
case, however, the eIects of the changed food item on obesity and
overall health are unclear. Similarly, the consumer may respond
to tax-induced price increases with substitution, i.e. consuming a
diIerent product. Again, the eIect of this substitution on energy
intake and health outcomes is uncertain (Miao 2013) and the
precise nature of the substitution may strongly depend on cultural,
geographical, and social factors. Price is only one determinant
among other environmental, social, and cultural factors that
influence consumption behaviour and individual diet (Dixon 2013).
Lastly, the manner by which the intervention is introduced and
implemented may impact its eIectiveness. For example, taxation
introduced primarily for revenue-raising purposes may not be set
at a high enough level to influence behaviour, or may not have an
impact on awareness of the adverse health consequences of the
product.
In Figure 1, we present a logic model showing the hypothesized
causal pathways between taxation of total fat/saturated fat and
obesity/other health outcomes. We anticipate that the introduction
of a tax on saturated fat/total fat may influence prices or
composition of food items, or both. The change in prices or
composition (or both) of food items may aIect buying behaviour
and, in turn, food consumption. Through a change in composition
or substitution (or both), the new diet may result in lower, higher, or
unaltered energy intake. Similarly, the intake of total fat, saturated
fat, and other nutrients will be influenced. These expected changes
may have beneficial eIects on obesity and other health outcomes.
 
Figure 1.   Logical model for taxation of saturated fat
 
Moreover, taxing a good depending on nutritional content sends
a strong signal from the government to consumers and producers
alike: the government is seriously concerned and is taking tangible
measures to curb consumption (Sassi 2016). For example, even if
the current level of taxation is low, once legislation for a tax is in
place it becomes much easier to increase the tax level in the future,
and the process of introducing a tax may raise awareness of the
adverse health eIects and facilitate behavioural change.
Why it is important to do this review
In their global strategy on diet, physical activity and health, the
World Health Assembly and the WHO stated that prices influence
consumption choices and that public policies can influence
prices through taxation, in ways that encourage healthy eating
(Waxman 2004; WHO 2014). Moreover, taxes are considered highly
cost-eIective public health actions as they may raise revenue
that outstrips implementation cost (Sassi 2014). This clearly
demonstrates the importance of tax interventions for public health.
The expected health eIect of a tax on fat has been repeatedly
suggested and analyzed in simulation studies for several countries
(Jørgensen 2013; Nnoaham 2009; Thiele 2010; TiIin 2011). Previous
systematic reviews have investigated taxes on foods linked to
obesity in general and also included simulation studies (e.g. Eyles
2012; Maniadakis 2013; Thow 2014). However, a systematic review
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of empirical evidence on the eIect of taxing fat is lacking, despite
existing examples of taxes on fat or saturated fat.
This research is part of a set of Cochrane Reviews of diIerent types
of food taxes, which are being carried out by the same author
group and share the same methodological approach. Our reviews
focus on the eIects of governmental taxation on (1) the fat content
of processed or packaged food (this review), (2) sugar-sweetened
beverages (Heise 2016), and (3) unprocessed sugar or sugar-added
foods (Pfinder 2016; Pfinder 2020).
O B J E C T I V E S
To assess the eIects of taxation of the fat content in food
on consumption of total fat and saturated fat, energy intake,
overweight, obesity, and other adverse health outcomes in the
general population.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Relevant evidence for this review was comprised of non-RCT
designs. This was expected, since the evaluation of real-world
taxation interventions is unlikely to be investigated in individual or
cluster-randomized studies (Lhachimi 2016b). Similarly, blinding is
almost impossible in the evaluation of national-level interventions.
Therefore, and in order to summarize the ‘best available evidence’,
we adapted an approach previously used in at least two other
Cochrane Reviews, which considers evidence from various sources
of the study designs (Gruen 2004; Turley 2013). This approach
clearly separates studies into two broad categories: (1) studies
meeting rigorous Cochrane EPOC (EPOC 2009; EPOC 2013) criteria,
and (2) supporting studies, which do not meet EPOC criteria, and
usually have a high risk of bias. According to EPOC, controlled
before-aLer studies require more than one intervention or control
site, and interrupted time series studies require a clearly-defined
intervention time and at least three data points before, and three
data points aLer, the intervention (EPOC 2013).
For the synthesis of the main results we included studies meeting
the following Cochrane EPOC criteria:
• randomized controlled trials (RCTs);
• cluster-randomized controlled trials (cRCTs);
• non-randomized controlled trials (nRCTs);
• controlled before-aLer (CBA) studies; and
• interrupted time series (ITS) studies.
There was no restriction in terms of publication date, publication
status, language of publication (CPH 2011), or study duration.
Supporting studies
In accordance with our published protocol, we included as
supporting studies (Lhachimi 2016b):
• studies using an RCT, cRCT, nRCT, CBA, or ITS design but not
fulfilling the EPOC criteria;
• prospective cohort studies;
• retrospective/non-concurrent cohort studies;
• repeated cross-sectional studies; and
• uncontrolled before-aLer (UBA) studies.
It was important to include supporting studies, since these may
either support or challenge the results in the main findings.
Also, supporting studies may highlight uncertainty and potential
research gaps.
We excluded simulation studies due to the potential limitations
introduced by their basic assumptions (e.g. lack of potential supply-
side changes, static models to predict weight loss), and other
methodological considerations (e.g. the use of a combination of
heterogeneous data sources) (Lin 2011; Shemilt 2015).
Types of participants
We included studies investigating participants of any age (children:
zero to 17 years, and adults: 18 years and over), of any gender and
from any country and setting.
We excluded studies that focused on specific subgroups only,
particularly those fulfilling the following criteria at baseline and at
the post-intervention phase, due to their higher or lower health
risks compared to the general population:
• people receiving pharmaceutical intervention;
• people undergoing a surgical intervention;
• pregnant females;
• professional athletes;
• ill people who are overweight or obese as a side eIect, such as
those with thyroiditis and depression; and
• people with chronic illness.
For these subgroups, the causal pathway of the eIect of a tax on the
fat content may diIer from the general population.
Types of interventions
This review included studies that evaluated the eIects of taxes on
the fat content in foods. Such a tax can be expressed as sales, excise,
or special VAT on the final product or an intermediary product
(Chriqui 2008; Chriqui 2013; Jou 2012; Mytton 2012). Taxation
may be calculated either as a share of the food’s weight, or as a
share of the food’s energy. Since the taxation of fat is designed to
incentivize the reduction in the amount of total or saturated fat in
the production of a food item, or at least to incentivize consumers'
replacement of saturated fat with other types of fat, we included
studies evaluating the eIect of fat taxation in both imported and
domestically-produced food items. The tax must have been applied
both for imports and domestically-produced food items.
We excluded virtual and hypothetical interventions imitating a
taxation on the fat content in foods if participants’ purchase
decisions are not binding so that they do not all result in a real
purchase or if the money is virtual or not belonging to the study
participant. We explicitly excluded import taxes that only target
selected food items that are high in fat, as this is usually not being
done to curb consumption of fats in general but to promote other
domestically-produced high-fat products (e.g. butter).
We placed no restrictions on the duration of the intervention or
whether taxation was applied at the local, regional, national, or
multinational level. Also, studies evaluating the eIects of artificial
price increases of high-saturated-fat food that mimic taxation
in clearly-defined environments (e.g. cafeterias, supermarkets,
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and vending machines) were considered eligible (Epstein 2012).
We included studies with any control intervention, such as no
intervention, as well as other food taxes, bans, minimum pricing,
media campaigns, or subsidies on healthy foods (Jou 2012; Thow
2011).
Types of outcome measures
Our outcome selection and grouping was guided by preliminary
evidence, as discussed in the Background section, on the basis of
the logic model (Figure 1), and feedback from the review advisory
board members (see Table 1). Detailed information on advisory
group involvement for this review is provided below. Primary
outcomes also include intermediate health-related outcomes
directly aIected by tax-induced changes in food prices. That is,
consumption and energy intake may directly alter the primary
health outcomes of overweight and obesity. Secondary outcomes
focused on food patterns (substitution and diet), expenditures, and
other health outcomes directly or indirectly influenced by taxation
of total fat/saturated fat content. We included demand, i.e. sales
data, as a proxy for consumption (see How the intervention might
work).
Primary outcomes
The review included changes from baseline to post-intervention for
the following primary outcomes.
Consumption
• Total fat consumption (e.g. frequency, amount)
• Consumption of saturated fat (e.g. frequency, amount)
Energy intake
• Total energy intake through fat
• Energy intake through saturated fat
• Total energy intake
Overweight and obesity
• Incidence of overweight and obesity
• Prevalence of overweight and obesity
All primary outcomes could be measured by physicians and
other professionals, or self-reported. Overweight and obesity can
be measured by diIerent anthropometric body mass indices,
e.g. body weight, BMI, skinfold thickness, waist circumference
(WC), waist-to-hip ratio (WHR), and waist-to-height ratio (WHtR),
bioelectrical impedance analysis (BIA), magnetic resonance
imaging (MRI), isotope dilution analysis (IDA), ultrasound, and
computed tomography (CT) (WHO 2000). We planned to report
changes in body mass indices if no data were available on the
incidence or prevalence of overweight and obesity.
Secondary outcomes
The review included changes from baseline to post-intervention for
the following secondary outcomes.
Substitution and diet
• Composition of diet (expressed as food groups or ingredients,
e.g. sugar, salt, fats)
Expenditures
• Total expenditures on food
• Total expenditures on processed or packaged food containing
fat or saturated fat
Demand
• Total sales of processed or packaged food containing fat or
saturated fat
Other health outcomes
• Health-related quality of life (e.g. Short Form 36 (SF-36), Health-
Related Quality of Life (HRQOL-14))
• Mortality
• Any other health outcomes (e.g. type 2 diabetes, cardiovascular
diseases)
Search methods for identification of studies
We conducted various searches in order to find all relevant evidence
for this review. We included systematic searches in electronic
databases, searching for grey literature, internet searching, and we
also undertook handsearching of reference lists of included studies.
Electronic searches
The search strategy was primarily developed for MEDLINE
via OvidSP, and adapted to the other electronic databases.
Our MEDLINE search strategy is documented in Appendix 1.
The adapted search strategy for other electronic databases is
documented in Appendix 2. Our search strategy was constructed
using free-text and controlled vocabulary. In order to increase the
sensitivity of our search strategy, we did not apply filters for study
types (Higgins 2019), or any other restrictions on publication date
or publication format. The initial search in all electronic databases
was conducted on 27 April 2016. We updated our search of all
included electronic databases on 6 December 2016, 12 January
2018, and 12 September 2019. In total, 12 academic databases were
searched:
• Campbell Library, via the Campbell Collaboration (2004 to 9
October 2019);
• Cochrane Central Register of Controlled Trials (CENTRAL; 2019,
Issue 10) via Wiley (searched 9 October 2019);
• Cochrane Database of Systematic Reviews (CDSR), via Wiley
(1995 to 9 October 2019);
• Cumulative Index to Nursing and Allied Health Literature
(CINAHL), via EBSCO (1937 to 12 September 2019);
• Current Contents Medicine Database of German and German-
Language Journals (CCMed), via LIVIVO (1917 to 14 October
2019);
• EconLit, via EBSCO (1969 to 9 October 2019);
• Excerpta Medica database (Embase), via OvidSP (1947 to 12
September 2019);
• Food Science and Technology Abstracts (FSTA), via OvidSP (1969
to 14 October 2019);
• Latin American and Caribbean Health Sciences (LILACS), via
BIREME/VHL (1982 to 12 September 2019);
• MEDLINE, via OvidSP (1946 to 12 September 2019);
• PsycINFO, via OvidSP (1887 to 9 October 2019); and
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• Web of Science (SCI-EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-SSH,
ESCI, CCR-EXPANDED, IC), via Clarivate Analytics (1900 to 12
September 2019).
Grey literature databases
Our search strategy for grey literature databases is documented in
Appendix 3. In total, we searched six databases, with the last update
in October 2019:
• EconPapers, via REPEC (1997 to 14 October 2019);
• National Bureau of Economic Research (NBER) (1920 to 13
October 2019);
• ProQuest Dissertations & Theses Database (PQDT): UK and
Ireland, via ProQuest (1637 to 9 October 2019);
• Social Science Research Network – SSRN eLibrary, via SSRN
(1994 to 14 October 2019);
• System for Information on Grey Literature in Europe – OpenGrey,
via OpenGrey (1994 to 9 October 2019); and
• The Directory of Open Access Repositories – OpenDOAR, via
OpenDOAR (1739 to 12 December 2016; this database was not
accessible in subsequent update searches).
Searching in clinical trial registries
Additionally, we searched for planned, ongoing, and completed
(but not yet published) studies in two databases, using sensitive
keywords relevant to the intervention (e.g. tax, taxation, pricing,
etc.):
• Trials Register of Promoting Health Interventions (TRoPHI),
via EPPI-Centre (2004 to 11 August 2016; the free-text search
function was not accessible in subsequent update searches);
and
• WHO International Clinical Trials Registry Platform (WHO ICTRP)
(includes references of the ClinicalTrials.gov database), via WHO
(1988 to 14 October 2019).
Internet search
We used the search engine Google Scholar and we also searched
web pages of key organizations and institutions. The search
strategy used in Google Scholar is documented in Appendix 4.
Searches were conducted on 11 August 2016, and on 14 October
2019. The first 30 hits were screened.
The websites of the following key organizations and institutions
were searched on 11 October 11 2019:
• Centers for Disease Control and Prevention (www.cdc.gov);
• DG Sanco (ec.europa.eu/dgs/health_food-safety/
index_en.htm);
• European Commission (ec.europa.eu/index_en.htm);
• National Institute for Health and Care Excellence
(www.nice.org.uk);
• Organisation for Economic Co-operation and Development
(www.oecd.org);
• WHO (www.who.int);
• World Cancer Research Fund Institute (www.wcrf.org);
• World Obesity Federation (www.worldobesity.org); and
• World Trade Organization (www.wto.org).
Searching other resources
We handsearched the reference lists of all included studies. We also
asked our advisory group members to inform us of new or ongoing
studies (see below for details). The last enquiry was on 26 February
2020 (Heise 2020).
Advisory group
We established a review advisory group of experts in the field
of food taxation and health to comment and provide advice and
suggestions to define important aspects along the review process.
The review advisory group consisted of policymakers, researchers
and academics. All members of the advisory group are documented
in Table 1.
Experts from the advisory group were active during the
protocol stage and gave advice on the definition of the specific
research question (including relevance of the topic, study
design, intervention, selected outcomes, search strategy and
relevant databases, etc.). Experts were also involved during the
development of the review, and during the preparation of this
manuscript. Feedback from the advisory group members was
collected via email and an online survey.
Following the GRADE approach, the advisory group members
participated in an online survey and ranked pre-selected outcomes
according to their relative importance on a nine-point Likert scale
with the following categories: one to three: of limited importance;
four to six: important; seven to nine: critical) (GRADE 2013). The
results are documented in Table 2.
Data collection and analysis
Selection of studies
An information specialist (CF) and an additional review author
(TLH) conducted the electronic database searches. One author
(MB, TLH, or SKL) searched for grey literature, studies in the
clinical trials registries, and conducted the internet searches.
The screening process was done using the web-based soLware
Covidence (Covidence; Rathbone 2015). First, titles and abstracts
(when available) were screened by at least two review authors
(MB, TLH, SKL, UG, GG, FP, IS, or SVK prior to 2018; MB, TLH, or
SKL in 2018 and 2019), independently from each other, considering
pre-defined eligibility criteria (see Criteria for considering studies
for this review). At this stage, only obviously irrelevant articles
were excluded. If an abstract was not provided by the database it
originated from, and the title appeared to be potentially relevant,
we progressed the record to full-text screening. We resolved any
disagreement by discussion and in consultation with a third author
(SKL, TLH or MB), and eliminated all records that did not fit
the inclusion criteria (see Criteria for considering studies for this
review). We then retrieved the full text of potentially relevant
records. These were screened by two review authors (FP and
SKL), independently from each other, who documented reasons
for excluding irrelevant articles. Both authors created a list with
records that were considered to fulfil the inclusion criteria; they
compared these lists and, in cases of disagreement, a third review
author (TLH) made the final decision. At each stage we recorded
the number of records retrieved and excluded in order to create the
PRISMA flow chart (Liberati 2009). If a reference, abstract or full-
text report was in a language other than English, German or French,
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translation was performed by internet-based translation tools or by
native speakers.
Data extraction and management
We used reference management soLware (Endnote 2012) to store
all records obtained by the electronic searches. Moreover, we used
this soLware to administer the results of abstract and full-text
screening. At least two review authors (FP, TLH, and SKL) extracted
data from the included full texts, while a third author resolved
disagreements (SKL or TLH). For this process, we modified the data
extraction and assessment template from Cochrane Public Health
(CPH) (CPH 2011) for the complex intervention addressed in this
review. Prior to the main data extraction process, MB, TLH, SVK,
UG, FP, and SKL piloted and adapted the data extraction form to
ensure standardized extraction. In accordance with our protocol
(Lhachimi 2016b), data extraction and assessment included general
information (publication type, country of study, funding source of
study, potential conflict of interest), study eligibility (type of study,
participants, type of intervention, duration of intervention, and
type of outcome measures), study details (study aim, methods,
results, intervention group, confounders, and confounder-adjusted
and unadjusted outcomes), indicators of changes in food prices,
and other relevant information. Moreover, we extracted contextual
factors that facilitate or hinder the implementation of the taxation
on fat contents of foods, where available (e.g. political system, co-
interventions, reason for implementation, reason for particular tax
level, intended beneficiaries, implementation costs, country and
region-specific level of gross domestic product (GDP), food security
(availability, access, and use), and process evaluation criteria
(e.g. satisfaction of participants, adherence) (Anderson 2011;
Campbell 2018). We also used the PROGRESS categories (place
of residence, race/ethnicity/culture/language, occupation, gender/
sex, religion, education, socioeconomic status, social capital) to
evaluate impacts on equity (O'Neill 2014).
References from all included studies were in English, thus no
translation from other languages was necessary. As defined in our
protocol, we contacted the authors of included studies to request
additional data and information not reported in the identified
publications.
Assessment of risk of bias in included studies
The risk of bias was evaluated for each included study
independently by two review authors (FP, TLH, and SKL), with a
third author (TLH or SKL) resolving disagreements. In accordance
with our protocol (Lhachimi 2016b), risk of bias was assessed
using diIerent tools, depending on the nature of the study design.
For the studies included in the main evidence synthesis (i.e. ITS
studies), we assessed the risk of bias using the Cochrane ‘Risk
of bias’ tool (Higgins 2011a), and the EPOC Group’s guidance
(EPOC 2013). Both tools examine the following domains: selection
bias, performance bias, detection bias, attrition bias, reporting
bias, and other sources of bias. The EPOC 'Risk of bias' tool for
ITS examines three further risks of bias: "was the intervention
independent of other changes?", "was the shape of the intervention
eIect pre-specified?" and "was the intervention unlikely to aIect
data collection?" (EPOC 2013). Each study was classified as having
a low, high, or unclear risk of bias. For each judgement, supporting
information was documented.
Risk of bias of 'supporting studies' (i.e. studies that did not meet
EPOC criteria: cohort studies, repeated cross-sectional studies,
uncontrolled before-aLer studies) was assessed with the Quality
Assessment Tool for Quantitative Studies, developed by the
EIective Public Health Practice Project (EPHPP 2010). This tool
examines the following domains: selection bias, study design,
confounders, blinding, data collection methods, withdrawals and
dropouts, intervention integrity, analysis, and a global rating. As a
result, each study is judged as having strong, moderate, or weak
evidence (EPHPP 2010).
Studies were assessed at the level of the whole study, as all
outcomes were considered to be comparable in risk of bias in this
review. Following assessment of each domain, the overall risk of
bias of a study was considered equal to the highest level of risk
assessed for an individual domain. For example, if at least one
domain was assessed as being at unclear risk, the study as a whole
was considered at unclear risk.
Measures of treatment eBect
For interrupted time series (ITS) studies, we reported the eIect
estimates as reported in each study. We confirmed that each ITS
study had been analysed in an appropriate manner, including
at least three time points before and aLer the intervention; a
clearly identified intervention point; accounting for a possible time
trend and possible seasonal eIects; and accounting for possible
autocorrelation (EPOC 2009; EPOC 2013; Polus 2017).
We did not identify more than one study per outcome measure,
therefore we were not able to conduct a meta-analysis. We intended
to report the eIects of the treatment on dichotomous outcomes
as odds ratios (ORs), risk ratios (RRs) or risk diIerences (RDs)
(Lhachimi 2016b). RRs are the preferred reported measure of
treatment eIect (CPH 2011). If RRs were not presented in a study,
but data to calculate the RRs were provided, we planned to
calculate them. This would have also applied for data suitable to
calculate ORs (e.g. obesity prevalence). If data to calculate the
RRs were not provided, we planned to contact the corresponding
author of the study by email or phone to request the RRs or the data
to calculate them. If we could not obtain RRs, we planned to report
the treatment eIect from the study report.
We planned to express continuous data as mean diIerences (MDs),
where applicable, or as standardized mean diIerences (SMDs).
Shorter ordinal data would have been translated into dichotomous
data (expressed as ORs, RRs, or RDs) and longer ordinal data would
have been treated as continuous data (expressed as MDs or SMDs).
It is unclear whether there is a cut-oI point which is common across
the studies and can be used for dichotomization (Higgins 2011a).
The cut-oI point would have been part of a sensitivity analysis. We
would have expressed count data and Poisson data as rate ratios.
Time-to-event data (survival data) would have been translated into
dichotomous data when appropriate, or into hazard ratios.
If feasible, we would have reported the adjusted treatment eIect.
If a study did not present adjusted treatment eIect measures, we
would have attempted to adjust the treatment eIect measures for
baseline variables by conducting additional multivariate analyses
as far as we had access to the data, or by contacting the
corresponding author of the study by email or phone to request the
adjusted treatment eIect measures. If studies presented intention-
to-treat eIect estimates, then we would have prioritized these over
average causal treatment eIect estimates (Higgins 2011a).
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When the treatment eIect had been described in cost estimates
as derived from economic studies, we would have converted the
cost estimates to US dollars (USD), and the price year to 2015,
to compare cost estimates from diIerent studies with each other.
To convert cost estimates into USD, we would have applied an
international exchange rate based on purchasing power parities.
To convert cost estimates to the year 2015, we would have applied
GDP deflators or implicit price deflators for GDP. Purchasing
power parity conversion rates and GDP deflator values would
have been derived from the International Monetary Fund in the
World Economic Outlook database (www.imf.org/en/Data) (Higgins
2011a).
Unit of analysis issues
In the published protocol we had planned to consider the unit of
analysis depending on study design (Lhachimi 2016b); in particular,
we would have considered issues such as accounting for the eIects
of clustering or the level of allocation to an intervention/control
group (i.e. individual or group). Since the included studies were ITS
and one UBA study as supporting study, which do not have a control
group, the unit of analysis was the study population included in
the study (either supermarket-level sales data or household-level
purchase data).
Dealing with missing data
We requested all missing information and data from study authors
by email (Lhachimi 2020; Lhachimi 2020a; Lhachimi 2020b). We
asked, in particular, for details on the study design, sample size, and
(additional) measures of statistical precision for all included studies
(see Characteristics of included studies).
According to our published protocol (Lhachimi 2016b) we intended
to request all missing information and data from principal
study authors by email or phone. In future updates of the
review, according to our published protocol (Lhachimi 2016b), the
following steps are to be taken to deal with relevant missing data:
• contact the authors;
• screen the study and investigate important numerical data such
as randomized individuals as well as intention-to-treat, as-
treated, and per-protocol populations;
• investigate attrition rates as part of the 'Risk of bias' assessment
in terms of dropouts, losses to follow-up and withdrawals;
• critically appraise issues of missing data and imputation
methods (e.g. last observation carried forward);
• impute missing standard deviations if the authors contacted do
not respond (Higgins 2011a); and
• apply sensitivity analyses to estimate the impact of imputation
on meta-analyses.
Data 'not missing at random' due to systematic loss to follow-up or
systematic exclusion of individuals from studies would have been
sought and requested from study authors (Higgins 2011a).
Assessment of heterogeneity
We planned to perform meta-analysis only where there
was no substantial heterogeneity between included studies
for a specific outcome (Lhachimi 2016b). Due to the low
number of included studies, we did not perform a meta-
analysis and therefore inspection of statistical heterogeneity
was not possible. Nevertheless, we narratively described the
methodological heterogeneity of the included studies, considering
study population, intervention characteristics, implementation
level, and outcomes.
Assessment of reporting biases
Reporting biases — including publication bias, time-lag bias,
multiple (duplicate) publication bias, location bias, citation bias,
language bias, and outcome reporting bias — occur when the
dissemination of research results depend on their magnitude and
direction (Higgins 2011a). We planned to inspect reporting bias with
funnel plots in the case that we had at least ten studies investigating
the same outcome (Lhachimi 2016b). Since this was not the case,
we were not able to analyze reporting bias with funnel plots.
Data synthesis
If two or more studies reported the same outcome and were
suIiciently homogenous conceptually, methodologically, and
statistically, we planned to perform meta-analyses of these
outcomes using Review Manager 5 (Review Manager 2014). Since
insuIicient studies were included to perform meta-analysis, results
were described narratively. To conduct narrative synthesis, we
considered direction of eIect as our common metric across studies
to establish whether there is evidence of an eIect of taxation
in the available literature. We grouped individual studies by
outcome categories, tabulated key information from each study,
and summarized the pattern of findings according to outcome
(Campbell 2020).
Subgroup analysis and investigation of heterogeneity
The included studies did not provide suIicient data to conduct
subgroup analysis. In the published protocol (Lhachimi 2016b), we
had planned to investigate the following subgroups for the primary
outcomes:
• high-income countries versus low- and middle-income
countries;
• high-income groups versus middle-income groups;
• single tax versus multiple taxes on fat content;
• tax on saturated fat alone versus tax on saturated fat
accompanied by other fat taxes;
• tax on fat accompanied by other interventions (e.g. bans,
minimum pricing, media campaigns, or subsidies of healthy
foods);
• diIerent types of taxation (e.g. excise tax or VAT);
• children versus adults; and
• BMI.
Sensitivity analysis
We had planned to conduct sensitivity analyses by removing
studies with a high risk of bias and by removing outliers
contributing to statistical heterogeneity (e.g. diIerent study
designs, sources of study funding, diIerent study follow-up times).
However, not enough studies were included in the review to
conduct sensitivity analysis.
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Summary of findings and assessment of the certainty of the
evidence
We generated a ‘Summary of findings’ table containing the
outcomes reported across the included studies. Additionally, in
accordance with our protocol (Lhachimi 2016b), we included
a ‘Summary of findings’ table for outcomes reported across
supporting studies. Based on the feedback provided by our
advisory board and external reviewers, we considered including at
least the following pre-selected outcomes: total fat consumption,
consumption of saturated fat, total energy intake, composition of
diet prevalence of overweight or obesity, and total sales. 'Summary
of findings' tables include information on the outcomes, results
provided by the study, the sample size, the number of studies
included, the quality of evidence based on GRADE (Schünemann
2013), and additional comments. The assessment was done by two
review authors (TLH and SKL). We used GRADEprofiler soLware to
prepare the ‘Summary of findings’ table (GRADE 2013; GRADEpro
GDT; Higgins 2011a).
Within the GRADE approach, the certainty of evidence is assessed
based on a number of factors which aIect the certainty of the
evidence. There are four possible levels of certainty (observational
studies with an ITS design begin with the level 'low certainty'):
• high-certainty (further research is very unlikely to change our
confidence in the estimate of eIect);
• moderate-certainty (further research is likely to have an
important impact on our confidence in the estimate of eIect and
may change the estimate);
• low-certainty (further research is very likely to have an
important impact on our confidence in the estimate of eIect and
is likely to change the estimate); and
• very low-certainty (any estimate of eIect is uncertain).
There are five factors that for which the certainty of evidence can
be downgraded:
• risk of bias of individual studies (limitations in the design and
implementation of available studies suggesting high likelihood
of bias);
• indirectness of evidence (indirect population, intervention,
control, outcomes);
• unexplained heterogeneity or inconsistency of results;
• imprecision of results; and
• high probability of publication bias.
There are three factors for which the certainty of evidence can be
upgraded:
• large magnitude of eIect;
• all plausible confounding would reduce a demonstrated eIect
or suggest a spurious eIect when results show no eIect; and
• dose-response gradient.
R E S U L T S
Description of studies
See Characteristics of included studies and Characteristics of
excluded studies.
Results of the search
We identified 23,281 records from searching electronic databases
and 1173 records from other sources (including grey literature
databases with 802 records), leading to a total of 24,454 records.
ALer removal of duplicates 18,767 records were included in the
abstract screening using Covidence. In total, we studied eight
articles at the full-text stage. Of these, five were excluded: four
considered a diIerent intervention (Elbel 2013; Hannan 2002; Khan
2015; Taillie 2017) and one was a modelling study (Smed 2016). This
resulted in two studies being included in the analysis (Jensen 2013;
Jensen 2015), and one supporting study (Bodker 2015 (supporting
study)). We documented the results of the study selection process
in a PRISMA flow diagram (Figure 2).
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Figure 2.   Study flow diagram.
 
We conducted our searches in intervals, with the last search taking
place in September 2019 (see Electronic searches for details).
Included studies
We included two studies (Jensen 2013; Jensen 2015), both of which
investigated the eIect of the Danish tax on the content of saturated
fat in selected food items.
Supporting studies
We included one study as a supporting study, which also
investigated the Danish tax (Bodker 2015 (supporting study)).
Study design and participants
Both included studies were retrospective ITS, fully compliant with
the EPOC criteria (EPOC 2009; EPOC 2013).
The first study (Jensen 2013) investigated the eIect of the Danish
fat tax on demand for selected food products that are high in
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fat content, i.e. butter, blends, margarine, and oil. The study
population was a panel of approximately 2000 Danish households
from 1 January 2009 to 1 July 2012. The panel was unbalanced
because about 20% of all households were replaced each year by
similar types of households. The participating households recorded
all their purchases by price and quantity. For the analysis, the
household purchases were aggregated to report weekly purchases.
The statistical model specification to estimate the eIect of
the intervention was a Tobit model, to account for households
that had zero consumption; it was also adjusted for household
characteristics and seasonal eIects. This study fulfills the criteria
as outlined by the EPOC guidance to be included as an ITS study,
i.e. at least three time points before and aLer the intervention; a
clearly identified intervention point; accounting for a possible time
trend and possible seasonal eIects; and accounting for possible
autocorrelation (EPOC 2009; EPOC 2013). Hence, the employed
study design is considered highly appropriate for ITS studies (Polus
2017).
The second study (Jensen 2015) investigated the eIect of the
Danish fat tax on demand for selected food products that are
potentially high in fat content, i.e. minced beef, regular cream, and
sour cream. The study populations were shoppers of a particular
Danish supermarket chain with a market share of approximately
40%. The authors analyzed the monthly sales volume and sales
revenue recorded by a balanced panel of 1,293 supermarkets (i.e.
the same supermarkets throughout the time period). For each
included food product the fat content was on record (National Food
Institute 2009). The statistical model specification to estimate the
eIect of the intervention on sales was a fixed-eIect regression
which accounted for seasonal eIects, time-trends and shiLs in
overall demand, in addition to the eIect of the intervention itself.
This study fulfills the criteria as outlined by the EPOC guidance
(EPOC 2009; EPOC 2013) to be included as an ITS study: i.e.
at least three time points before and aLer the intervention; a
clearly identified intervention point; accounting for a possible time
trend and possible seasonal eIects; and accounting for possible
autocorrelation. Hence, the employed study design is considered
highly appropriate for ITS studies (Polus 2017).
Supporting studies
The supporting study (Bodker 2015 (supporting study)) was an UBA
that did not have a suIicient number of observed time points
before and aLer the intervention to fulfil the EPOC criteria for
an ITS study. The main objective of the study was to project
the health eIects of changes in consumption of saturated fat
using a simulation tool. The analysis of sales data was merely an
input into the simulation tool and change in population-level risk
for ischemic heart disease was the simulation output. The study
population was shoppers from all Danish outlet chains (except two
discounts chains); the number of supermarkets or observations in
the analysis were not reported. The data covered the total sales
of 12 food products high in fat content, i.e. butter, butter blends,
margarine, fat, oil, cheese, cream, sour cream, chips, snacks,
cookies, and biscuits. For all food products the fat content was
calculated. The sales data were collected for the first 28 weeks of
each year under observation (2010 to 2013) and aggregated into a
single time point for each year.
Intervention
The two studies included in this review (Jensen 2013; Jensen 2015)
investigated the eIect of the Danish tax on saturated fat. The tax
came into eIect on 1 October 2011, and was subsequently repealed
by an act of parliament in November 2012. Hence, the tax was still
implemented until 31 December 2012. The tax covered only certain
food types, including meat, full-fat dairy products, animal fats,
edible oils, and margarine; it exempted food items with a saturated
fat content of 2.3% or less. The tax was designed as an excise tax and
the rate was set at 16 Danish krone (DKK) (approximately USD 2.90
in 2012) per kilogram of saturated fat contained in the food item,
plus 25% VAT (see Jensen 2015 for more details).
Jensen 2013 covered a pre-intervention period from 1 January 2009
to 30 September 2011 (196 weeks); the actual intervention period
started on 1 October 2011 and lasted for 39 weeks until the end of
the study. The authors accounted for a potential hoarding eIect by
including a dummy variable for the two-week period before the tax
was implemented.
Jensen 2015 covered a pre-intervention period from 1 January 2010
to 30 September 2011 (91 weeks); the actual intervention period
started on 1 October 2011 for 57 weeks until the end of the study
(31 October 2012). The authors accounted for a potential hoarding
eIect by including a dummy variable for the month September of
2011 (i.e. four weeks before implementation of the tax).
Supporting studies
Bodker 2015 (supporting study) also investigated the Danish tax,
and covered a pre-intervention period for 48 weeks in total:
from January 2010 to July 2010 (28 weeks) and January 2011
to July 2011 (28 weeks). The actual intervention period was
covered for 28 weeks from January 2012 to July 2012, and the
post-intervention period ranged from January 2013 to July 2013
(28 weeks). Therefore, the period directly before and aLer the
implementation of the intervention was excluded.
Context and implementation
All included studies investigated the eIect of a particular
intervention, i.e. the Danish tax on saturated fat. Discussions in
Denmark on a tax on saturated fat can be traced back to 2009. The
underlying idea of proposing such a tax was to use diIerentiated
pricing on food products to incentivize healthy eating habits and
increase overall population health (CoP 2009). In August 2009, the
first draL of the tax bill was introduced in parliament and the final
version of the bill was discussed in parliament in January 2011; it
finally passed in March 2011. The proposed tax rate was changed
during the discussion of the bill from initially DKK 25 to DKK 13 and
finally to DKK 16 for each kilogram of saturated fat. Additionally, a
threshold of 2.3% saturated fat in the products was set, exempting
all products with less saturated fat content, in particular regular
drinking milk and milk-based yoghurts.
Some scholars have argued that the main motivation of the Danish
government for introducing the tax was primarily to raise additional
revenue, not to improve population health (Bødker 2015a; Jensen
2018; Jørgensen 2016; Vallgarda 2015). For example, the tax was
part of a larger package of financial bills and the final level of the tax
on saturated fat content was determined in such a way to ensure
a certain amount of revenue to oIset the costs of simultaneously
decreasing taxes on labour (Bødker 2015a). Moreover, the Danish
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government had no plans for monitoring the health consequences
of the bill, although the revenue eIects of the bill were to be
monitored closely (Vallgarda 2015). Similarly, the main argument
for the repeal was economic. In particular, the cost for companies
and retailers in administering the tax and also job losses for food
producers were put forward as the main arguments against the tax.
Additionally, the tax received substantial negative media coverage.
Already in November 2012, the parliament voted to repeal the tax,
starting 1 January 2013. Hence, the tax was in eIect for 15 months
and no evaluation of the health eIects of the bill was published
during this period (Vallgarda 2015).
Outcome measures
Primary outcomes
Both studies reported estimates for the consumption of at least one
primary outcome measure: Jensen 2013 reported on the total fat
consumption, and Jensen 2015 on the saturated fat consumption.
Both studies, however, used the changes in sales/purchases of
food products (collected at store or household-level) as a proxy to
estimate from those changes the average change at the individual
level. No study recorded consumption or intake at the individual
level. None of the included studies reported on the incidence of
overweight or obesity.
Jensen 2013 included only four diIerent types of food products
that are rich in fats and saturated fat, i.e. butter, blends, margarine,
and oil. The household purchases of these four food products were
measured as grams per week, summed up and divided by the
number of individuals in the household, in order to estimate the
total fat consumption per person. Possible variations in the actual
level of fat content of the diIerent products were not accounted for.
Moreover, no estimate was given about the level of saturated fat
content.
Jensen 2015 included only three diIerent types of food products
(i.e. minced beef, regular cream, and sour cream), subdivided into
products with low fat content (less than 7% fat content), medium
fat content (7% to 11% fat content), and high fat content (more
than 11% fat content). According to the study authors, these three
types of food products jointly represent an estimated 10% to 15% of
Danes’ total intake of saturated fat. The average change in sales of
these food products was estimated using the pooled supermarket
sales data. The saturated fat content of total sales was calculated
using product-specific coeIicients for saturated fat content using
the Danish Food Composition Database (National Food Institute
2009). For their estimate of the average percentage change in
saturated fat consumption, based on changes of total sales of all
three products, the authors did not report confidence intervals,
significance levels (i.e. P values), or any other measure about the
statistical precision of their eIect estimates.
Secondary outcomes
Substitution and diet
Jensen 2015 reported the changes in the distribution of sales as
a consequence of the tax for all three included food products,
i.e. from a high-fat variety to a medium- or low-fat variety, based
on supermarket sales data. The authors, however, did not report
confidence intervals, significance levels (i.e. P values), or any other
measure about the statistical precision of their eIect estimates.
Supporting studies
Bodker 2015 (supporting study) reported the total sales of all food
products under investigation in metric tonnes. They also reported
percentage changes in sales for all included food products.
However, they did not report confidence intervals, significance
levels (i.e. P values), or any other measure about the statistical
precision of their eIect estimates.
Funding and conflict of interests
Jensen 2015 received funding from the Danish Ministry of Science,
and the authors declared that they have no conflicts of interests.
Jensen 2013 did not state any sources of funding and did not
provide a statement about potential conflicts of interests.
Supporting studies
Bodker 2015 (supporting study) received funding from the Danish
Health Foundation ('Helsefonden', a charity foundation to improve
population health), and the authors declared that they have no
conflicts of interest.
Excluded studies
We excluded five studies from our analysis. The study by Smed
2016 combined estimates for sales reduction (which were not
reported) with heterogeneous data sources (e.g. additional survey
data collected at diIerent time points) and therefore constituted
a modelling study. Two studies did not investigate a tax as an
intervention (Hannan 2002; Khan 2015), and two further studies did
not target to tax the fat content of food (Elbel 2013; Taillie 2017).
Full details for exclusion are shown in Characteristics of excluded
studies.
Studies awaiting classification
We did not identify any study awaiting classification.
Ongoing studies
We did not identify any ongoing studies.
Risk of bias in included studies
Judgements from the 'Risk of bias' assessment are summarized
under Characteristics of included studies. The included studies
(both of which had an ITS design) were judged overall to have an
unclear risk of bias (Jensen 2013; Jensen 2015). Figure 3 shows the
'Risk of bias' judgement for each domain of each included study and
the supporting study.
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Figure 3.   Risk of bias summary: review authors' judgements about each risk of bias item for each included study
(blank cells indicate that the particular domain was not assessed for the study).
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Allocation
Generation of allocation sequence and adequate concealment of
allocation sequence is not applicable in ITS studies (according to
the EPOC criteria).
Blinding
The intervention itself, a national tax, was not blinded. However,
the participants in all studies were not aware that their data
were used to investigate the eIect of the tax. Hence, the risk of
performance bias was judged to be low for both studies included.
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Intervention independent of other changes
The intervention in all included studies was a legislative act that did
not have health outcomes as a motivation and was implemented
without any cointervention. Hence, we judged the risk of bias for
this domain to be low for all studies.
Shape of eBect pre-specified
For all included studies, the shape of the eIect of implementing
a tax on saturated fat was pre-specified, informed by micro-
economic theory before testing the intervention eIect. Hence, we
judged the risk of bias for this domain to be low for all included
studies.
Intervention unlikely to aBect data collection
For all included studies the analysis was done using databases that
are permanent data collections for the purpose of market research
(either household panels or through supermarket cashiers). The
data collection was initiated several years before the intervention
and was also continued several years aLer the data collection.
Hence, we judged the risk of bias for this domain to be low for all
included studies.
Incomplete outcome data
Jensen 2013 reported that their unbalanced panel had an annual
attrition/replacement level of 20%. No further analysis was
provided to what extent this attrition and replacement may aIect
outcome measures. Hence, we judged the risk of bias in this domain
as unclear. Jensen 2015 did not report on the completeness of their
outcome data, and so we judged the risk of bias in this domain as
unclear.
Selective reporting
None of the studies were based on published study protocols,
however, the outcomes described in the methods sections were
reported. This is not unusual for ITS studies. The data were derived
from databases that are permanent, commercial data collections
for the purpose of market research potentially covering a wide
range of products, yet both studies only included certain food types
and did not provide a clear rationale for selecting particular food
products. Hence, we judged the risk of bias for both studies as
unclear.
Other potential sources of bias
The data in Jensen 2013 was based on consumer panels where
households self-record their shopping (prices and quantities).
Such households might be more price-sensitive than the general
population, where individuals may or may not have the same
level of awareness concerning changes in prices or their spending
patterns (or both). We judged the risk of bias from this source as
being unclear.
Risk of bias in supporting studies
The risk of bias of the included supporting study (Bodker 2015
(supporting study)) was assessed using the EPHPP criteria, and was
judged as weak (i.e. the study was rated as having weak evidence).
EBects of interventions
See: Summary of findings 1 Taxation of the fat content of foods
compared to no taxation for reducing their consumption and
preventing obesity or other adverse health outcomes
EBects of taxation of the fat content of food for reducing their
consumption and preventing obesity or other adverse health
outcomes
The eIects of taxation of the fat content of food were investigated
in two included studies without any control group. As we did not
identify more than one study per outcome measure, we were not
able to conduct a meta-analysis. Thus, we have summarized the
results narratively in the following section.
A summary of the findings on the eIects of the taxation of the fat
content of food, based on the two included studies, is presented in
Summary of findings 1. For an overview of the studies, see Table 3.
Primary outcomes
Consumption
Changes in total fat consumption
This outcome was reported in one of the included studies, which
analyzed the eIect of Danish tax on saturated fat for a selection
of four food products: butter, blends, margarine, and oil (Jensen
2013). The study population consisted of approximately 2000
households (no individual participant data) and the results showed
a mean reduction in total fat consumption of 41.8 grams per
week per person in each household (P < 0.001; no precise P value
was reported), based on the four food products investigated. Our
calculations show this is equivalent to a reduction of approximately
six grams per person per day. We judged the certainty of this
evidence to be very low, according to GRADE criteria.
Changes in consumption of saturated of fat
One of the included studies (Jensen 2015) assessed changes in
consumption of diIerent types of fat. The study investigated
sales data from 1293 Danish supermarkets, in order to estimate
consumption of selected food products (minced beef, regular
cream, and sour cream). The authors reported a mean percentage
reduction of the saturated fat content of all minced beef sales
of 4.2%, and a reduction of 5.8% of saturated fat content of all
cream sales. However, they did find a slight increase of 0.5% for
the saturated fat content of the total sales of sour cream. The study
did not report absolute values for this outcome, and no measures
of statistical precision were reported for any of these results. The
direction of the eIect is in line with expectations from economic
theory, i.e. an increase in price leads to a decrease in consumption.
However, we judged the certainty of the evidence for the total
saturated fat consumption to be very low, according to GRADE
criteria.
Energy intake
None of the included studies reported on total energy intake
through fat, energy intake through saturated fat, or total energy
intake.
Overweight and obesity
None of the included studies reported on the incidence or
prevalence of overweight and obesity.
Taxation of the fat content of foods for reducing their consumption and preventing obesity or other adverse health outcomes (Review)
Copyright © 2020 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The Cochrane
Collaboration.
18
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
Secondary outcomes
Substitution and diet
Jensen 2015 reported estimates that showed substitution eIects
within one product category (e.g. low- and medium-fat versus high-
fat minced beef), according to the sales data from 1293 Danish
supermarkets. The demand for high-fat minced meat decreased by
10.6%, while the demand for low-fat minced meat increased by
5.1%. Similarly, demand for low-fat sour cream increased by 4.6%,
while the demand for the high-fat variety decreased by 8.6%. No
measures of statistical precision were reported for any of these
results. The direction of this eIect is in line with the expectation
from economic theory.
Expenditures
None of the included studies reported on total expenditures
on food or total expenditures on processed or packaged food
containing fat or saturated fat.
Demand
None of the included studies reported on changes in overall
demand. Nevertheless, a crucial element about the intervention
investigated in this review is to know if (and to what extent) an
excise tax is being passed on to the consumer, i.e. do producers
and retailers raise prices on products (see Figure 1)? This was the
case for the Danish tax on saturated fat as investigated by the two
studies included in this review. Jensen 2013 reported data from
approximately 2000 households, that discount stores passed on
taxes in full to consumers for blends and oils; and for butter and
margarine the pass-on rate was even higher than the expected
amount, that is, the retailers used the implementation of the
tax to increase profit margins. For non-discounting supermarkets,
the pass-on rate for the four product categories investigated
was slightly lower than for discount supermarkets. Moreover,
Jensen 2015 showed that prices for the high-fat variety of minced
beef, cream, and sour cream increased by 16% (P < 0.01; no
precise P value was reported), 14% (P < 0.01; no precise P
value was reported), and 13% (P < 0.01; no precise P value was
reported), respectively (according to sales data from 1293 Danish
supermarkets). The prices for the low-fat variety of these products
decreased slightly, by 1% for minced beef (not significant; no
precise P value was reported), 2% for cream (P < 0.01; no precise P
value was reported), and 1% for sour cream (P <0.01; no precise P
value was reported).
Supporting studies
Bodker 2015 (supporting study) reported on the total sales of
selected food products from Danish outlet chains (the number of
supermarkets or observations in the analysis were not reported).
The study showed that, for the food products under investigation,
total sales decreased by 911 metric tonnes, a decrease of 0.9%
(no measure of statistical precision was reported). They also found
that the total sales increased by 1.3% from 2010 to 2011 (the time
before the tax implementation). An increase of 1.3% (no measure of
statistical precision was reported) was also observed from 2012 to
2013, which is the time aLer the tax was abolished.
Other health outcomes
None of the included studies reported on health-related quality of
life (e.g. Short Form 36 (SF-36) or Health-Related Quality of Life
(HRQOL-14)); mortality; or any other health outcomes (e.g. type 2
diabetes, cardiovascular diseases).
D I S C U S S I O N
Summary of main results
We aimed to assess the eIects of taxation of fat content in food
on consumption of total fat and saturated fat, energy intake,
overweight, obesity, and other adverse health outcomes in the
general population. In our search, we identified 23,281 records
from searching electronic databases and 1173 records from other
sources — in particular, grey literature databases, from which
we retrieved 802 records — leading to a total of 24,454 records.
We included two studies in the analysis, both of which were
interrupted time series (ITS) studies; additionally, we analyzed one
uncontrolled before-aLer study as a supporting study. We judged
the overall risk of bias of the two included studies as 'unclear',
and the supporting study as 'weak'. We were not able to conduct a
meta-analysis because we did not identify more than one study per
outcome measure.
For the primary outcome, total consumption of fat, a mean
reduction of 41.8 grams per week per person in each household (P
value < 0.001; no precise P value was reported) was identified. We
calculated that this equates to a mean diIerence of approximately
-6 grams per person, per day. Considering that the average total fat
intake in Denmark is 111 grams per day (standard deviation: 39.1
grams per day) for males, and 83 grams per day (standard deviation:
28.8 grams per day) for females — i.e. 777 grams per week for males
and 581 grams per week for females — we consider the reduction
of 6 grams per day to be clinically meaningful (Nadelmann 2015).
However, this estimate is based on a restricted number of food
types and does not account for other sources of fat intake that
were not included in the study. For example, packaged foods
or foods consumed at other outlets (e.g. restaurants, cafeterias,
etc.) were not included. Furthermore, the analysis did not account
for heterogeneity in the fat consumption pattern of households
or individuals, which vary in Denmark by age, sex, and other
characteristics such as income and education (Rasmussen 2012).
Hence, we judged the evidence about the eIect of taxation of fat
contents of food on consumption of total fat to be very uncertain.
One study reported a reduction in the sales of selected food items
high in saturated fat content, e.g. minced beef; similarly, we judged
the evidence on the eIect of taxation of fat contents of food on
consumption of saturated fat to be very uncertain.
Comparing the identified evidence with our logical model, we are a
very uncertain about the eIect of the Danish tax. However, for a very
limited number of food items that were investigated in the included
study, we can identify that the Danish tax had a detectable influence
on certain prices and consumer behaviour: supermarkets altered
their prices and consumers altered their purchases (Figure 4 shows
the adapted logical model). However, only a restricted number
of food products were part of the analysis, and no statement
on the overall eIect on prices and consumer behaviour can be
made. For example, cheese or other dairy such as ice cream
were not included; also no packaged or pre-processed foods were
investigated. Moreover, other food outlets such as convenience
stores, restaurants, or cafeterias were not covered by the studies.
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Figure 4.   Adapted logical model
 
Due to the very low certainty of the evidence for the identified
outcomes (total fat and saturated fat consumption), and the
absence of evidence on other outcomes (i.e. total energy intake,
incidence and prevalence of overweight or obesity), we cannot
be certain about the direction and absolute eIect of the taxation
intervention on total fat or saturated fat consumption. Moreover,
we cannot be certain about the direction and absolute eIect of
substituting taxed food products with other more or less harmful
products or behaviours.
Overall completeness and applicability of evidence
The body of evidence based on the identified studies is incomplete.
We identified only one country which evaluated the eIects of
implementing a tax on fat contents on food. Primary outcome
measures were either addressed insuIiciently (consumption of fat)
or not at all (energy intake, overweight and obesity). Moreover,
all identified studies used sales data only (either recorded at
the supermarket or the household level). Hence, there is no
information on how individual diet and individual fat intake
(as is oLen collected in nutrition surveys) changed due to the
intervention. Sales data were also usually recorded either at store-
level or at household-level, which represents a heterogeneous
study population that cannot be accounted for (e.g. households
may have children or not, etc.). Also, the sales data do not account
for purchases in food outlets or for fat intake outside the household;
and none of the studies considered the potential impact of cross-
border shopping (a practice to exploit taxation diIerentials, which
has been well-studied in Nordic countries (Asplund 2001)). The
studies may not be representative of the Danish population,
because they are based on convenience samples (supermarket-
level sales data or existing consumer panels of a private company).
Moreover, the included study investigated only one particular
intervention in Denmark only; this limits the applicability of the
findings to other settings/countries, and other designs of the tax
intervention.
We planned to include certain studies as supporting studies to
increase the possible evidence base. Despite their methodological
limitations, supporting studies may enable more insight on the
intermediate steps, as depicted in our logical model, of the causal
pathway of a taxation of the fat or saturated fat content of food.
The supporting study we included (Bodker 2015 (supporting study))
also indicated that overall food demand changed when the Danish
tax was implemented.
Quality of the evidence
We assessed the certainty of evidence as very low for reducing
consumption of total fat or saturated fat. We had to downgrade
the findings of the primary outcomes due to indirectness: firstly,
because the studies by Jensen 2013 and Jensen 2015 focused
only on certain food products (although the databases used —
self-recorded household purchase and supermarket sales data —
in principle may contain all sold food products); and secondly,
because sales/purchases of food items was used as a proxy
to measure consumption. Moreover, we had to downgrade the
findings for total saturated fat consumption and substitution due to
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imprecision, since no measure of statistical precision was reported.
We did not identify any evidence on the eIect of the intervention
on total energy intake, energy intake through saturated fat or total
fat, or prevention of the incidence or reduction of the prevalence of
overweight or obesity.
Several additional limitations must be acknowledged. First, the
included studies conducted their analysis only with a limited
number of food types. These studies cannot account fully for
substitution eIects of shoppers. Hence, we do not have information
about the change in total fat consumption or saturated fat
consumption. Second, these studies use already-existing data sets
that potentially cover a much larger range of food types that could
be included in the analysis. There is no clear rationale as to why
the included food types were selected and others not. This strongly
indicates that analysis of already-existing data should be guided
by prespecified protocols. Finally, none of the included studies
investigated any health-related outcomes, including potential
harms or adverse events.
Potential biases in the review process
We are confident that we identified all present or past eligible
interventions, i.e. taxation of the fat content of food products. As
our review is part of a larger project concerning the taxation of
food products to curb overweight/obesity and other adverse health
outcomes (Heise 2016; Pfinder 2020), we believe that we would
be aware of applicable interventions in other countries, especially
considering the public nature of tax legislation and the relatively
large administrative eIort needed to implement such a tax in
jurisdiction. Moreover, we contacted our advisory board members
regularly to ask if they were aware of any ongoing studies (Heise
2020). For the only applicable case, the Danish tax on saturated fat,
we are suIiciently confident that we identified all eligible published
studies. However, it is unclear to what extent private companies
conducted market research on the changes in sales of aIected food
products that remained unpublished.
We did not make any major changes during the review process
compared with our published protocol (Lhachimi 2016b) (see
DiIerences between protocol and review for further details). Hence,
we judge the potential risk of bias in this review process as low.
Agreements and disagreements with other studies or
reviews
We are not aware of any other studies or systematic reviews about
the eIect of taxation of fat or saturated fat content in food.
A U T H O R S '   C O N C L U S I O N S
Implications for practice
Due to the very low certainty of the available evidence, we are not
able to conclude whether a tax on fat or saturated fat is eIective
or ineIective in reducing total consumption of fat or saturated fat.
Moreover, we did not identify any evidence on whether a tax on fat
or saturated fat is eIective or ineIective at reducing total energy
intake, the incidence or prevalence of overweight or obesity, or
other adverse health outcomes.
Implications for research
High-quality studies on the eIect of a tax on fat or saturated fat
are needed in order to understand its eIectiveness in reducing
the consumption of fat/saturated fat, and thereby preventing
obesity or other adverse health outcomes. It is notable that we did
not identify any study with a dedicated epidemiological research
objective and more comprehensive research design, as is available
for legislation on the availability of alcohol (Nelson 2017). The
eIectiveness of taxation cannot be studied using a standard RCT
approach; instead, natural experimental studies are required (Craig
2017). Considering this, the Danish taxation on saturated fat from
2011 to 2012 is a missed opportunity for public health research,
especially in light of the evidence we identified to suggest it had
a detectable influence on certain prices and consumer behaviour.
To our knowledge, no prospective research project was planned or
initiated by the Danish authorities.
Even though the Danish fat tax is now abolished, more
comprehensive research about its eIects is, in principle, feasible.
An advantage of ITS studies is that they can be used to
retrospectively analyze data that have been already collected
(perhaps originally for a diIerent purpose). The existing data
on household purchases should be investigated using a more
comprehensive approach, that is, including all food types and not
only a limited number. Nevertheless, reliable studies on nutrition
intake are very demanding in terms of research design and should
preferably always be prospective; and even a well-conducted ITS
study cannot establish the same level of certainty as a well-
designed and conducted RCT. Moreover, the Danish fat tax (and
the oversights in terms of formally evaluating it) is a good example
of the need to implement a health in all policies (HiaP) approach
(Kickbusch 2013), a crucial element of which is to conduct health
impact assessment of all policies, including those that do not
intend to influence health. Such HiaPs should be conducted before
the implementation of a policy, but also aLer the implementation
to evaluate the actual impact of a policy (Lhachimi 2012; Lhachimi
2013). Investigating the impact of the withdrawal of the tax may
also be fruitful (Craig 2018).
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Methods Study design: uncontrolled before-after (UBA)
Study location/setting: Denmark
Timing: retrospective
Allocation to group: not applicable (study without control group)
Database: Nielsen Scan Track
Year of study: 2015
Duration of the study: January 2010 to July 2013 (112 weeks; only the first 28 weeks of each calendar
year were included in the study).
Pre-intervention: January 2010 to July 2010; January 2011 to July 2011 (56 weeks)
Intervention: January 2012 to July 2012 (28 weeks)
Post-intervention: January 2013 to July 2013 (28 weeks)
Unit of analysis: supermarkets (data aggregated to the whole nation)
Participants Study population: shoppers from all Danish outlet chains (except two discount chains); the study did
not include individual participant data.
Country: Denmark
Age: all ages
Sex: all sexes
Socioeconomic characteristics: different socioeconomic groups
Eligibility criteria: not applicable
Inclusion criteria: not applicable
Recruitment: not applicable
Equity considerations: not applicable
Interventions Intervention: Danish tax on saturated fat, imposed on food items with more than 2.3% saturated fat
(e.g. not covering regular drinking milk or yoghurts). The tax level was set DKK 16 (approximately USD
2.90) for each kilogram of saturated fat.
Outcomes Primary outcome
None (see notes)
Secondary outcome
Demand: total sales for different type of food products (in metric tonnes) for the first 24 weeks of the
years 2010 to 2014.
Notes This was used as a supporting study in our review.
The study contains tables showing estimates for average daily consumption of different types of fat
in kilojoules/person and average proportions of energy intake out of total energy intake for different
types of fats; however, those estimates are based on combining heterogeneous data sources in addi-
tion to the study data and, hence, are not directly observed ( a modelling study). We contacted the cor-
responding author to request details concerning clarifications and additional data (e.g. sample size,
measures of statistical precision), however, the author was not in a position to provide these data.
Funding sources: Danish Health Foundation (2013B228)
Bodker 2015 (supporting study)  (Continued)
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Conflicts of interest: the authors reported to have no conflicts of interest.
Risk of bias
Bias Authors' judgement Support for judgement
EPHPP Criteria Unclear risk Component Ratings
A) Selection bias
Q1) Are the individuals selected to participate in the study likely to be repre-
sentative of the target population? Somewhat likely (automatically collected
sales data covering all supermarkets except 2 discount chains)
Q2) What percentage of selected individuals agreed to participate? Not applic-
able (automatically collected sales data independent of the intervention)
Rating (section A): moderate
B) Study design
Indicate the study design: uncontrolled before-after
Was the study described as randomized? No
Rating (section B): weak
C) Confounders
Q1) Were there important differences between groups prior to the interven-
tion? Not applicable
Q2) If YES, indicate the percentage of relevant confounders that were con-
trolled (either in design (e.g. stratification, matching) or analysis)? Not applica-
ble
Rating (section C): weak
D) Blinding
Q1) Was (were) the outcome assessor(s) aware of the intervention or exposure
status of participants? No (automatically collected sales data independent of
the intervention)
Q2) Were the study participants aware of the research question? No (automati-
cally collected sales data independent of the intervention)
Rating (section D): strong
E) Data collection methods
Q1) Were data collection tools shown to be valid? Unknown
Q2) Were data collection tools shown to be reliable? Unknown
Rating (section E): weak
F) Withdrawals and dropouts
Q1) Were withdrawals and dropouts reported in terms of numbers and/or rea-
sons per group? Not applicable
Q2) Indicate the percentage of participants completing the study. (If the per-
centage differs by groups, record the lowest). Not applicable
Bodker 2015 (supporting study)  (Continued)
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Rating (section F): weak
G) Intervention integrity
Q1) What percentage of participants received the allocated intervention or ex-
posure of interest? 80% to 100%
Q2) Was the consistency of the intervention measured? Not applicable
Q3) Is it likely that subjects received an unintended intervention (contamina-
tion or cointervention) that may influence the results? No
H) Analyses
Q1) Indicate the unit of allocation. Community (nation)
Q2) Indicate the unit of analysis. Community, because aggregated to the whole
nation
Q3) Are the statistical methods appropriate for the study design? No (primary
outcomes); Yes (secondary outcome).
Q4) Is the analysis performed by intervention allocation status (i.e. inten-
tion-to-treat) rather than the actual intervention received? Not applicable
Global rating for this paper: weak
Bodker 2015 (supporting study)  (Continued)
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Methods Study design: interrupted time series (ITS) complying with the Effective Practice and Organisation
of Care (EPOC) group (EPOC 2009; EPOC 2013) criteria, i.e. at least three time points before and after
the intervention; a clearly identified intervention point; accounting of a possible time trend and possi-
ble seasonal effects; and accounting for possible autocorrelation. The precise model specification is a
Tobit model (to account for the possibility of zero consumption) with correlated random-effects and
defining season dummies for each month and for Christmas, and also a linear and quadratic overall
time trend.
Study location/setting: Denmark
Timing: retrospective
Allocation to group: not applicable (study without control group)
Database: GfK Panel Service Denmark
Year of study: 2013
Duration of the study: 1 January 2008 to 1 July 2012 (235 weeks)
Pre-intervention: 1 January 2008 to 30 September 2011 (196 weeks)
Intervention: 1 October 2011 until the end of the study (39 weeks) - only selected food products, i.e.
butter blends, margarine, and oil.
Participants Study population: approximately 2000 households (the study did not include individual participant
data)
Country: Denmark
Age: all ages
Jensen 2013 
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Sex: all sexes
Socioeconomic characteristics: different socioeconomic groups
Eligibility criteria: not applicable
Inclusion criteria: the study was based on a commercial Danish household panel for the purpose of
market research aiming to be representative for the whole population. However, the study does con-
tain more detailed information on recruitment.
Equity considerations: only households willing to participate in recording their purchases are includ-
ed; this may exclude vulnerable parts of the population such as the homeless.
Interventions Intervention: Danish tax on saturated fat covering food items with more than 2.3% saturated fat (e.g.
not covering regular drinking milk or yoghurts). The tax level was set at DKK 16 (approximately USD
2.90) for each kilogram of saturated fat.
Outcomes Primary Outcome
Consumption: changes in total fat intake per household in grams per week (calculations based on the
four mentioned food products)
Secondary Outcome
None reported (see notes)
Notes We contacted the corresponding author to request details concerning clarifications and additional da-
ta (e.g. sample size, measures of statistical precision), however the author was not in position to pro-
vide these data.
Funding sources: not reported.
Conflicts of interest: authors did not provide any information about conflicts of interests.
The study contains tables about changes in the demand of the three food products; however, these es-
timates are based on a different, restrictive statistical model that does not account for the full tax effect
(Jensen 2020; Jensen 2020a).
Risk of bias
Bias Authors' judgement Support for judgement
Blinding of participants
and personnel (perfor-
mance bias)
All outcomes
Low risk Although the intervention was not blinded, participants were not aware that
their data were used to investigate the effect of the tax.
Blinding of outcome as-
sessment (detection bias)
All outcomes
Low risk Although the intervention was not blinded, participants were not aware that
their data were used to investigate the effect of the tax.
Incomplete outcome data
(attrition bias)
All outcomes
Unclear risk Authors reported that their unbalanced panel had an annual attrition/replace-
ment level of 20%. No further analysis was provided to indicate what extent
this attrition and replacement may affect outcome measures.
Selective reporting (re-
porting bias)
Unclear risk The study had no published study protocol. The outcomes described in the
methods section were reported, however, data were derived from databases
that are permanent, commercial data collections for the purpose of market re-
search potentially covering a wide range of products. Additionally, the study
included certain food types without a clear rationale for selecting particular
food products.
Jensen 2013  (Continued)
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Intervention independent
of other changes (ITS)
Low risk The intervention was a legislative act that did not have health outcomes as a
motivation.
Cointerventions were reported.
Shape of effect pre-speci-
fied (ITS)
Low risk Shape of effect of intervention was prespecified.
Intervention unlikely to af-
fect data collection (ITS)
Low risk Sources and methods of data collection were the same before and after the in-
tervention:
self-reported shopping data from a permanent consumer panel for market re-
search.
Other bias Unclear risk People who self-collect shopping data might be more price-sensitive than the
general population.
Jensen 2013  (Continued)
 
 
Study characteristics
Methods Study design: interrupted time series (ITS) complying with the EPOC (EPOC 2009; EPOC 2013) crite-
ria: i.e. at least three time points before and after the intervention; a clearly identified intervention
point; accounting of a possible time trend and possible seasonal effects; and accounting for possible
autocorrelation. The precise model specification is a linear almost ideal demand system (LAIDS), using
three stage least square with fixed effects with regards to stores and defining season dummies for each
month (Wooldridge 2007).
Study location/setting: Denmark
Timing: retrospective
Allocation to group: not applicable (study without control group)
Number of individuals: sales data from a balanced panel of 1293 supermarkets
Database: Coop Danmark (Danish food retailer with 40% market share)
Year of study: 2015
Duration of the study: 1 January 2010 to 31 October 2012 (148 weeks)
Pre-intervention: 1 January 2010 to 30 September 2011 (91 weeks)
Intervention: 1 October 2011 (57 weeks until end of study duration)
Unit of analysis: supermarket level
Participants Study population: Coop Denmark supermarkets
Country: Denmark
Age: all ages
Sex: all sexes
Socioeconomic characteristics: different socioeconomic groups
Eligibility criteria: not applicable
Inclusion criteria: all Danish supermarkets that belong to a sales co-operative
Jensen 2015 
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Recruitment: no information given
Equity considerations: not applicable
Interventions Intervention: Danish tax on saturated fat covering food items with more than 2.3% saturated fat (e.g.
not covering regular drinking milk or yoghurts). The tax level was set at DKK 16 (approximately USD
2.90) for each kilogram of saturated fat.
Outcomes Primary Outcome
Consumption: monthly changes in per cent of total purchased saturated fat based on the average fat
content of different food products (for minced beef, regular cream, sour cream)
Secondary Outcome
Substitution: monthly changes in percent of total purchased food products, which are rich in fats (i.e.
minced beef, regular cream, sour cream)
Notes We contacted the corresponding author to request details concerning clarifications and additional da-
ta (e.g. sample size, measures of statistical precision), however, the author was not in position to pro-
vide this data.
Funding sources: the authors reported that the project was part of a large research centre ‘UNIK –
Food,
Pharma, Fitness’ at the University of Copenhagen.
The centre has obtained financial support from the Danish Ministry of Science.
Conflict of Interest: the authors declare that they have no competing interests.
Risk of bias
Bias Authors' judgement Support for judgement
Blinding of participants
and personnel (perfor-
mance bias)
All outcomes
Low risk Although the intervention was not blinded, participants were not aware that
their data were used to investigate the effect of the tax.
Blinding of outcome as-
sessment (detection bias)
All outcomes
Low risk Although the intervention was not blinded, participants were not aware that
their data were used to investigate the effect of the tax.
Incomplete outcome data
(attrition bias)
All outcomes
Unclear risk The authors did report on the completeness of their outcome data.
Selective reporting (re-
porting bias)
Unclear risk The study had no published study protocol. The outcomes described in the
methods section were reported, however, data were derived from databases
that are permanent, commercial data collections for the purpose of market re-
search potentially covering a wide range of products. Additionally, the study
included certain food types, without providing a clear rationale for selecting
particular food products.
Intervention independent
of other changes (ITS)
Low risk The intervention was a legislative act that did not have health outcomes as a
motivation.
No cointerventions were reported.
Shape of effect pre-speci-
fied (ITS)
Low risk Shape of the effect of the intervention was prespecified.
Jensen 2015  (Continued)
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Intervention unlikely to af-
fect data collection (ITS)
Low risk Sources and methods of data collection were the same before and after the in-
tervention:
sales data collected through supermarket electronic cashier.
Other bias Low risk We did not identify other sources of bias.
Jensen 2015  (Continued)
EPHPP: EIective Public Health Practice Project
 
Characteristics of excluded studies [ordered by study ID]
 
Study Reason for exclusion
Elbel 2013 Intervention was not a tax on fat content; no measurement of baseline data before the intervention
Hannan 2002 Intervention was not a tax but a subsidy of low-fat foods.
Khan 2015 Intervention was not a tax, but evidence based on (natural) variation of milk prices and not an ac-
tive price manipulation of a product.
Smed 2016 The estimates for the primary outcome measure combined heterogeneous data sources and there-
fore this constituted a modelling study; sales data were not reported.
Taillie 2017 Intervention was not a tax on fat content; the intervention was applied indiscriminately to high-
caloric foods in general.
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Table 1.   Advisory group members 
 
 
1.1. Rank outcomes according to their relative importance for the scope of the reviews and general public health deci-
sion-making in the context of food taxation; 9-point Likert scale (categories: 1 to 3 = of limited importance; 4 to 6 = important; 7 to
9 = critical)
Outcomes: Average score: Rank:
Table 2.   Feedback from advisory group 
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Prevalence of overweight 7.67 3
Prevalence of obesity 7.67 3
Incidence of overweight 8.00 1
Incidence of obesity 8.00 1
Caloric intake through SSBs or unprocessed sugar/sugar-added foods 7.33 8
Total calorie consumption 6.67 11
Consumption of sugar-sweetened beverages (SSBs) or unprocessed sugar/sug-
ar-added foods (e.g. frequency, amount)
7.33 8
Health-related quality of life 4.00 16
Total sales of SSBs or unprocessed sugar/sugar-added foods 5.33 15
Composition of diet (e.g. fat, sugar, salt) 6.67 11
Total expenditures on food 4.00 16
Total expenditures on SSBs or unprocessed sugar/sugar-added foods (e.g. fre-
quency, amount)
5.67 14
Any health outcomes or health-related unintended consequences 7.67 3
- e.g. mortality 7.00 10
- e.g. dental caries 6.00 13
- e.g. diabetes 7.67 3
- e.g. cardiovascular disease 7.67 3
2.1. How well do the presented outcomes cover the basic review scope?
Answers: Rating: Number of respons-
es:
Important outcomes are presented 66.67% 2
Important outcomes are missing 33.33% 1
Comments: I imagine some evidence will be presented as
simply a change in BMI or other markers of
obesity rather than a change in incidence or
prevalence of obesity (Cristina Cleghorn).
3.1. Do you think the same outcomes are appropriate for both reviews (SSB; sugar or sugar-added foods)?
Answers: Rating: Number of respons-
es:
The same group of outcomes should be utilized in both reviews 66.67% 2
Table 2.   Feedback from advisory group  (Continued)
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Different outcomes should be utilised in the two reviews 33.33% 1
Comments: Foods study: hard to go beyond kcal and
weight and minimal cardio metabolic out-
comes as the Morenga et al. review shows (Bar-
ry Popkin).
Table 2.   Feedback from advisory group  (Continued)
 
 
Study Study
Design
Overall
risk of
Bias
Inter-
vention
Measurement of outcome Description of effect
Consumption of total fat  
Jensen
2013
ITS
(2000
house-
holds)
Unclear Danish
tax on
saturat-
ed fat
Calculations of change in total fat are based on (1)
selected food products (i.e. butter, blends, mar-
garines, and oils), (2) using sales as proxy for con-
sumption, and (3) assumptions about average
consumption per person in a household
A decrease in total fat content
consumption
Consumption of saturated fat
Jensen
2015
ITS
(1293 su-
permar-
kets)
Unclear Danish
tax on
saturat-
ed fat
Calculations of change in saturated fats are based
on (1) selected food products (i.e. minced beef,
cream, sour cream), (2) using sales as proxy for
consumption, and (3) using data from a particular
supermarket chain covering 40% of market share
A decrease in saturated fat
consumption from minced
beef and cream, and an in-
crease from sour cream
Substitution
Jensen
2015
ITS
(1293 su-
permar-
kets)
Unclear Danish
tax on
saturat-
ed fat
Calculations to what extend a high-fat variety of a
food item is substituted by low-fat variety of this
food item based on (1) selected food products (i.e.
minced beef, cream, sour cream), (2) using sales
as proxy for consumption, and (3) using data from
a particular supermarket chain covering 40% of
market share
Substitution effect within one
product category from the
high variety to a low fat vari-
ety (e.g. more sales of low- and
medium-fat and less sales of
high-fat minced beef)
Demand  
Bodker
2015
(sup-
porting
study)
UBA (un-
clear
num-
ber of
includ-
ed shop-
pers)
Weak Danish
tax on
saturat-
ed fat
Change of total sales of selected food products in
shoppers from Danish outlet chains measures, in
metric tonnes per year.
Total sales of selected food
products decreased in the year
while the tax was implement-
ed, while also showing that in
the year before and after the
tax was implemented, total
sales increased.
Table 3.   Overview of included studies and supporting studies by outcome 
ITS: interrupted time series
UBA: uncontrolled before-aLer
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A P P E N D I C E S
Appendix 1. MEDLINE search strategy
12 September 2019
4235 records
1. exp Taxes/
2. exp Government Programs/ec, lj [Economics, Legislation & Jurisprudence]
3. exp Health Policy/ec, lj [Economics, Legislation & Jurisprudence]
4. exp Food Dispensers, Automatic/ec, lj, sn [Economics, Legislation & Jurisprudence, Statistics & Numerical Data]
5. exp Health Promotion/ec, lj [Economics, Legislation & Jurisprudence]
6. exp Nutrition Policy/ec, lj [Economics, Legislation & Jurisprudence]
7. exp Public Health/ec, lj [Economics, Legislation & Jurisprudence]
8. "demand elasticity".tw.
9. "policy intervention*".tw.
10. "sales tax".tw.
11. "thin subsidies".tw.
12. "vending machine*".tw.
13. budget.tw.
14. excise.tw.
15. fiscal.tw.
16. levied.tw.
17. levy.tw.
18. price.tw.
19. priced.tw.
20. prices.tw.
21. pricing.tw.
22. subsidy.tw.
23. subsidies.tw.
24. tax.tw.
25. taxation.tw.
26. taxed.tw.
27. taxes.tw.
28. taxing.tw.
29. OR/1-28
30. exp Dietary Carbohydrates/
31. exp Dietary Sucrose/
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32. exp High Fructose Corn Syrup/
33. "chewing gum".tw.
34. "dietary sucrose".tw.
35. (("energy dens*" or "highenergy" or "high energy" or "high-energy" or "low energy" or chips) and (fat* or sugar* or sweet* or food or
diet* or nutrition or overweight or drink* or beverage* or protein* or carbohydrate*)).tw.
36. "HED calori*".tw.
37. "HED-calori*".tw.
38. "highcalori* food*".tw.
39. "high calori* food*".tw.
40. "high-calori* food*".tw.
41. "lowcalori* food*".tw.
42. "low calori* food*".tw.
43. "low-calori* food*".tw.
44. "ice cream*".tw.
45. "unhealthy food*".tw.
46. bakery.tw.
47. biscuit*.tw.
48. cacao.tw.
49. cake*.tw.
50. calorie*.tw.
51. candy.tw.
52. candies.tw.
53. bonbon*.tw.
54. chocolate*.tw.
55. confectionar*.tw.
56. cookie*.tw.
57. isoglucose.tw.
58. jam.tw.
59. jelly.tw.
60. jellies.tw.
61. liquorice.tw.
62. macronutrient*.tw.
63. maltose.tw.
64. marmalade.tw.
65. marzipan.tw.
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66. pastr*.tw.
67. sucrose.tw.
68. sugar.tw.
69. sugars.tw.
70. sugary.tw.
71. sweet*.tw.
72. exp Butter/
73. exp Dietary Fats/
74. exp Energy Intake/
75. exp Fast Foods/
76. exp Margarine/
77. exp Plant Oils/ec [Economics]
78. "fastfood*".tw.
79. "fast food*".tw.
80. "fast-food*".tw.
81. "fattening-food*".tw.
82. "fattening food*".tw.
83. "fried food*".tw.
84. (coconut OR cooking OR palm OR vegetable OR soya OR soybean OR rapeseed OR linseed OR sunflower OR sesame OR peanut OR
groundnut OR copra OR babassu OR olive OR thistle ADJ Oil).tw.
85. "salty-snack*".tw.
86. "salty snack*".tw.
87. "snack food*".tw.
88. "snack-food*".tw.
89. "takeaway food*".tw.
90. "takeaway-food*".tw.
91. "take away food*".tw.
92. "take away-food*".tw.
93. "take-away food*".tw.
94. "take-away-food*".tw.
95. "whole milk".tw.
96. burger*.tw.
97. butter.tw.
98. cheese.tw.
99. cream.tw.
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100. crisps.tw.
101. (egg AND (fat* or sugar* or sweet* or food or diet* or nutrition or overweight or drink* or beverage* or protein* or carbohydrate*)).tw.
102. (eggs AND (fat* or sugar* or sweet* or food or diet* or nutrition or overweight or drink* or beverage* or protein* or carbohydrate*)).tw.
103. (fat AND (Food* or diet* or nutrition or nutrient or eat* or meal* or oil* or carbohydrate* or protein* or obesity or obese)).tw.
104. (fatty AND (Food* or diet* or nutrition or nutrient or eat* or meal* or oil* or carbohydrate* or protein* or obesity or obese)).tw.
105. fats.tw.
106. fattening.tw.
107. fries.tw.
108. ghee.tw.
109. lard.tw.
110. margarine.tw.
111. mono-unsat*.tw.
112. monounsat*.tw.
113. omega3.tw.
114. "omega 3".tw.
115. omega-3.tw.
116. pizza.tw.
117. polyunsat*.tw.
118. poly-unsat*.tw.
119. sausage*.tw.
120. suet.tw.
121. exp Carbonated Beverages/
122. exp Food Preferences/
123. exp Food Habits/
124. "caloric-drink*".tw.
125. "caloric drink*".tw.
126. "carbonated-beverage*".tw.
127. "carbonated beverage*".tw.
128. "carbonated-drink*".tw.
129. "carbonated drink*".tw.
130. "energy-drink*".tw.
131. "energy drink*".tw.
132. "fizzy-drink*".tw.
133. "fizzy drink*".tw.
134. "high-calori* drink*".tw.
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135. "high calori* drink*".tw.
136. "soda pop".tw.
137. "soL-drink*".tw.
138. "soL drink*".tw.
139. "sport-drink*".tw.
140. "sport* drink*".tw.
141. "sport*-drink*".tw.
142. cola.tw.
143. soda.tw.
144. SSB*.tw.
145. syrup*.tw.
146. OR/30-145
147. 29 AND 146
148. (animals NOT (humans AND animals)).sh.
149. 147 NOT 148
Appendix 2. Search strategies for electronic academic databases
Cochrane Central Register of Controlled Trials (CENTRAL) via Wiley (1948 to present)
9 October 2019
425 records
#1. MeSH descriptor: [Taxes] explode all trees
#2. MeSH descriptor: [Government Programs] explode all trees and with qualifier(s): [Economics - EC, Legislation & jurisprudence - LJ]
#3. MeSH descriptor: [Health Policy] explode all trees and with qualifier(s): [Economics - EC, Legislation & jurisprudence - LJ]
#4. MeSH descriptor: [Food Dispensers, Automatic] explode all trees
#5. MeSH descriptor: [Health Promotion] explode all trees and with qualifier(s): [Economics - EC, Legislation & jurisprudence - LJ]
#6. MeSH descriptor: [Nutrition Policy] explode all trees and with qualifier(s): [Economics - EC, Legislation & jurisprudence - LJ]
#7. MeSH descriptor: [Public Health] explode all trees and with qualifier(s): [Economics - EC, Legislation & jurisprudence - LJ]
#8. "demand elasticity"
#9. "policy intervention*"
#10. "thin subsidies"
#11. "vending machine*"
#12. budget
#13. excise
#14. fiscal
#15. levied
#16. levy
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#17. price
#18. priced
#19. prices
#20. pricing
#21. subsidy
#22.subsidies
#23.tax
#24. taxation
#25. taxed
#26. taxes
#27. taxing
#28. #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14 or #15 or #16 or #17 or #18 or #19 or #20 or #21 or
#22 or #23 or #24 or #25 or #26 or #27
#29. MeSH descriptor: [Dietary Carbohydrates] explode all trees
#30. MeSH descriptor: [Dietary Sucrose] explode all trees
#31. "chewing gum"
#32. "dietary sucrose"
#33. "energy dens*"
#34. "highenergy"
#35. "high energy"
#36. "high-energy"
#37. "low energy"
#38. chips
#39. "highcalori* food*"
#40. "high calori* food*"
#41. "high-calori* food*"
#42. "low-calori* food*"
#43. "ice cream*"
#44. "unhealthy food*"
#45. bakery
#46. biscuit*
#47. cacao
#48. cake*
#49. calorie*
#50. candy
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#51. candies
#52. bonbon*
#53. chocolate*
#54. confectionar*
#55. cookie*
#56. isoglucose
#57. jam
#58. jelly
#59. jellies
#60. liquorice
#61. macronutrient*
#62. maltose
#63. marmalade
#64. marzipan
#65. pastr*
#66. sucrose
#67. sugar
#68. sugars
#69. sugary
#70. sweet*
#71. MeSH descriptor: [Butter] explode all trees
#72. MeSH descriptor: [Dietary Fats] explode all trees
#73. MeSH descriptor: [Energy Intake] explode all trees
#74. MeSH descriptor: [Fast Foods] explode all trees
#75. MeSH descriptor: [Margarine] explode all trees
#76. MeSH descriptor: [Plant Oils] explode all trees
#77. "fastfood*"
#78. "fast food*"
#79. "fast-food*"
#80. "fattening-food*"
#81. "fattening food*"
#82. "fried food*"
#83. "coconut oil"
#84. "cooking oil"
#85. "palm oil"
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#86. "vegetable oil"
#87. "soya oil"
#88. "soybean oil"
#89. "rapeseed oil"
#90. "linseed oil"
#91. "sunflower oil"
#92. "sesame oil"
#93. "peanut oil"
#94. "groundnut oil"
#95. "copra oil"
#96. "babassu oil"
#97. "olive oil"
#98. "thistle oil"
#99. "salty-snack*"
#100. "salty snack*"
#101. "snack food*"
#102. "snack-food*"
#103. "takeaway food*"
#104. "takeaway-food*"
#105. "take away food*"
#106. "take away-food*"
#107. "take-away food*"
#108. "take-away-food*"
#109. "whole milk"
#110. burger*
#111. butter
#112. cream
#113. crisps
#114. egg
#115. eggs
#116. fat
#117. fatty
#118. fats
#119. fries
#120. lard
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#121. mono-unsat*
#122. monounsat*
#123. omega3
#124. "omega 3"
#125. omega-3
#126. polyunsat*
#127. poly-unsat*
#128. sausage*
#129. suet
#130. MeSH descriptor: [Carbonated Beverages] explode all trees
#131. MeSH descriptor: [Food Preferences] explode all trees
#132. MeSH descriptor: [Food Habits] explode all trees
#133. "caloric-drink*"
#134. "caloric drink*"
#135. "carbonated-beverage*"
#136. "carbonated beverage*"
#137. "carbonated-drink*"
#138. "carbonated drink*"
#139. "energy-drink*"
#140. "energy drink*"
#141. "fizzy-drink*"
#142. "fizzy drink*"
#143. "high-calori* drink*"
#144. "high calori* drink*"
#145. "soda pop"
#146. "soL-drink*"
#147. "soL drink*"
#148. "sport-drink*"
#149. "sport* drink*"
#150. "sport*-drink*"
#151. cola
#152. soda
#153. SSB*
#154. syrup*
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#155. #29 or #30 or #31 or #32 or #33 or #34 or #35 or #36 or #37 or #38 or #39 or #40 or #41 or #42 or #43 or #44 or #45 or #46 or #47 or #48
or #49 or #50 or #51 or #52 or #53 or #54 or #55 or #56 or #57 or #58 or #59 or #60 or #61 or #62 or #63 or #64 or #65 or #66 or #67 or #68 or
#69 or #70 or #71 or #72 or #73 or #74 or #75 or #76 or #77 or #78 or #79 or #80 or #81 or #82 or #83 or #84 or #85 or #86 or #87 or #88 or #89
or #90 or #91 or #92 or #93 or #94 or #95 or #96 or #97 or #98 or #99 or #100 or #101 or #102 or #103 or #104 or #105 or #106 or #107 or #108
or #109 or #110 or #111 or #112 or #113 or #114 or #115 or #116 or #117 or #118 or #119 or #120 or #121 or #122 or #123 or #124 or #125
or #126 or #127 or #128 or #129 or #130 or #131 or #132 or #133 or #134 or #135 or #136 or #137 or #138 or #139 or #140 or #141 or #142 or
#143 or #144 or #145 or #146 or #147 or #148 or #149 or #150 or #151 or #152 or #153 or #154
#156. #155 and #28 in Trials
Cochrane Database of Systematic Reviews (CDSR) via Wiley (1995 to present)
9 October 2019
66 records
#1 tax or taxes or taxation
#2 food or sugar or sweet or sweets or sweetened or fast food or snacks or fat or fats or fatty or soL drinks
#3 #1 and #2
Excerpta Medica database (Embase) via OvidSP (1947 to present)
12 September 2019
6797 records
1. exp Tax/
2. exp government regulation/
3. "demand elasticity".tw.
4. "policy intervention*".tw.
5. "sales tax".tw.
6. "thin subsidies".tw.
7. "vending machine*".tw.
8. budget.tw.
9. excise.tw.
10. fiscal.tw.
11. levied.tw.
12. levy.tw.
13. price.tw.
14. priced.tw.
15. prices.tw.
16. pricing.tw.
17. subsidy.tw.
18. subsidies.tw.
19. tax.tw.
20. taxation.tw.
21. taxed.tw.
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22. taxes.tw.
23. taxing.tw.
24. or/1-23
25. exp carbohydrate intake/
26. exp corn syrup/
27. sugar intake/
28. sweetening agent/
29. "chewing gum".tw.
30. "dietary sucrose".tw.
31. (("energy dens*" or "highenergy" or "high energy" or "high-energy" or "low energy" or chips) and (fat* or sugar* or sweet* or food or
diet* or nutrition or overweight or drink* or beverage* or protein* or carbohydrate*)).tw.
32. "HED calori*".tw.
33. "HED-calori*".tw.
34. "highcalori* food*".tw.
35. "high calori* food*".tw.
36. "high-calori* food*".tw.
37. "lowcalori* food*".tw.
38. "low calori* food*".tw.
39. "low-calori* food*".tw.
40. "ice cream*".tw.
41. "unhealthy food*".tw.
42. bakery.tw.
43. biscuit*.tw.
44. cacao.tw.
45. cake*.tw.
46. calorie*.tw.
47. candy.tw.
48. candies.tw.
49. bonbon*.tw.
50. chocolate*.tw.
51. confectionar*.tw.
52. cookie*.tw.
53. isoglucose.tw.
54. jam.tw.
55. jelly.tw.
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56. jellies.tw.
57. liquorice.tw.
58. macronutrient*.tw.
59. maltose.tw.
60. marmalade.tw.
61. marzipan.tw.
62. pastr*.tw.
63. sucrose.tw.
64. sugar.tw.
65. sugars.tw.
66. sugary.tw.
67. sweet*.tw.
68. exp butter/
69. exp fat intake/
70. exp caloric intake/
71. exp fast food/
72. exp margarine/
73. exp food preference/
74. exp milk fat/
75. "fastfood*".tw.
76. "fast food*".tw.
77. "fast-food*".tw.
78. "fattening-food*".tw.
79. "fattening food*".tw.
80. "fried food*".tw.
81. ((coconut or cooking or palm or vegetable or soya or soybean or rapeseed or linseed or sunflower or sesame or peanut or groundnut
or copra or babassu or olive or thistle) adj Oil).tw.
82. "salty-snack*".tw.
83. "salty snack*".tw.
84. "snack food*".tw.
85. "snack-food*".tw.
86. "takeaway food*".tw.
87. "takeaway-food*".tw.
88. "take away food*".tw.
89. "take away-food*".tw.
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90. "take-away food*".tw.
91. "take-away-food*".tw.
92. "whole milk".tw.
93. burger*.tw.
94. butter.tw.
95. cheese.tw.
96. cream.tw.
97. crisps.tw.
98. (egg and (fat* or sugar* or sweet* or food or diet* or nutrition or overweight or drink* or beverage* or protein* or carbohydrate*)).tw.
99. (eggs and (fat* or sugar* or sweet* or food or diet* or nutrition or overweight or drink* or beverage* or protein* or carbohydrate*)).tw.
100. (fat and (Food* or diet* or nutrition or nutrient or eat* or meal* or oil* or carbohydrate* or protein* or obesity or obese)).tw.
101. (fatty and (Food* or diet* or nutrition or nutrient or eat* or meal* or oil* or carbohydrate* or protein* or obesity or obese)).tw.
102. fats.tw.
103. fattening.tw.
104. fries.tw.
105. ghee.tw.
106. lard.tw.
107. margarine.tw.
108. mono-unsat*.tw.
109. monounsat*.tw.
110. omega3.tw.
111. "omega 3".tw.
112. omega-3.tw.
113. pizza.tw.
114. polyunsat*.tw.
115. poly-unsat*.tw.
116. sausage*.tw.
117. suet.tw.
118. "caloric-drink*".tw.
119. "caloric drink*".tw.
120. "carbonated-beverage*".tw.
121. "carbonated beverage*".tw.
122. "carbonated-drink*".tw.
123. "carbonated drink*".tw.
124. "energy-drink*".tw.
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125. "energy drink*".tw.
126. "fizzy-drink*".tw.
127. "fizzy drink*".tw.
128. "high-calori* drink*".tw.
129. "high calori* drink*".tw.
130. "soda pop".tw.
131. "soL-drink*".tw.
132. "soL drink*".tw.
133. "sport-drink*".tw.
134. "sport* drink*".tw.
135. "sport*-drink*".tw.
136. cola.tw.
137. soda.tw.
138. SSB*.tw.
139. syrup*.tw.
140. exp dietary intake/
141. or/25-140
142. 24 and 141
PsycINFO via OvidSP (1887 to present)
9 October 2019
1978 records
1. exp Taxation/
2. exp Policy Making/
3. exp Government Programs/
4. exp Government Policy Making/
5. "demand elasticity".tw.
6. "policy intervention*".tw.
7. "sales tax".tw.
8. "thin subsidies".tw.
9. "vending machine*".tw.
10. budget.tw.
11. excise.tw.
12. fiscal.tw.
13. levied.tw.
14. levy.tw.
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15. price.tw.
16. priced.tw.
17. prices.tw.
18. pricing.tw.
19. subsidy.tw.
20. subsidies.tw.
21. tax.tw.
22. taxation.tw.
23. taxed.tw.
24. taxes.tw.
25. taxing.tw.
26. or/1-25
27. exp Carbohydrates/
28. exp Food Intake/
29. exp Sugars/
30. "chewing gum".tw.
31. "dietary sucrose".tw.
32. (("energy dens*" or "highenergy" or "high energy" or "high-energy" or "low energy" or chips) and (fat* or sugar* or sweet* or food or
diet* or nutrition or overweight or drink* or beverage* or protein* or carbohydrate*)).tw.
33. "HED calori*".tw.
34. "HED-calori*".tw.
35. "highcalori* food*".tw.
36. "high calori* food*".tw.
37. "high-calori* food*".tw.
38. "lowcalori* food*".tw.
39. "low calori* food*".tw.
40. "low-calori* food*".tw.
41. "ice cream*".tw.
42. "unhealthy food*".tw.
43. bakery.tw.
44. biscuit*.tw.
45. cacao.tw.
46. cake*.tw.
47. calorie*.tw.
48. candy.tw.
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49. candies.tw.
50. bonbon*.tw.
51. chocolate*.tw.
52. confectionar*.tw.
53. cookie*.tw.
54. isoglucose.tw.
55. jam.tw.
56. jelly.tw.
57. jellies.tw.
58. liquorice.tw.
59. macronutrient*.tw.
60. maltose.tw.
61. marmalade.tw.
62. marzipan.tw.
63. pastr*.tw.
64. sucrose.tw.
65. sugar.tw.
66. sugars.tw.
67. sugary.tw.
68. sweet*.tw.
69. exp Eating Behavior/
70. exp Fast Food/
71. exp Fatty Acids/
72. "fastfood*".tw.
73. "fast food*".tw.
74. "fast-food*".tw.
75. "fattening-food*".tw.
76. "fattening food*".tw.
77. "fried food*".tw.
78. ((coconut or cooking or palm or vegetable or soya or soybean or rapeseed or linseed or sunflower or sesame or peanut or groundnut
or copra or babassu or olive or thistle) adj Oil).tw.
79. "salty-snack*".tw.
80. "salty snack*".tw.
81. "snack food*".tw.
82. "snack-food*".tw.
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83. "takeaway food*".tw.
84. "takeaway-food*".tw.
85. "take away food*".tw.
86. "take away-food*".tw.
87. "take-away food*".tw.
88. "take-away-food*".tw.
89. "whole milk".tw.
90. burger*.tw.
91. butter.tw.
92. cheese.tw.
93. cream.tw.
94. crisps.tw.
95. (egg and (fat* or sugar* or sweet* or food or diet* or nutrition or overweight or drink* or beverage* or protein* or carbohydrate*)).tw.
96. (eggs and (fat* or sugar* or sweet* or food or diet* or nutrition or overweight or drink* or beverage* or protein* or carbohydrate*)).tw.
97. (fat and (Food* or diet* or nutrition or nutrient or eat* or meal* or oil* or carbohydrate* or protein* or obesity or obese)).tw.
98. (fatty and (Food* or diet* or nutrition or nutrient or eat* or meal* or oil* or carbohydrate* or protein* or obesity or obese)).tw.
99. fats.tw.
100. fattening.tw.
101. fries.tw.
102. ghee.tw.
103. lard.tw.
104. margarine.tw.
105. mono-unsat*.tw.
106. monounsat*.tw.
107. omega3.tw.
108. "omega 3".tw.
109. omega-3.tw.
110. pizza.tw.
111. polyunsat*.tw.
112. poly-unsat*.tw.
113. sausage*.tw.
114. suet.tw.
115. exp "Beverages (Nonalcoholic)"/
116. exp Food Preferences/
117. "caloric-drink*".tw.
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118. "caloric drink*".tw.
119. "carbonated-beverage*".tw.
120. "carbonated beverage*".tw.
121. "carbonated-drink*".tw.
122. "carbonated drink*".tw.
123. "energy-drink*".tw.
124. "energy drink*".tw.
125. "fizzy-drink*".tw.
126. "fizzy drink*".tw.
127. "high-calori* drink*".tw.
128. "high calori* drink*".tw.
129. "soda pop".tw.
130. "soL-drink*".tw.
131. "soL drink*".tw.
132. "sport-drink*".tw.
133. "sport* drink*".tw.
134. "sport*-drink*".tw.
135. cola.tw.
136. soda.tw.
137. SSB*.tw.
138. syrup*.tw.
139. or/27-138
140. 26 and 139
Current Contents Medicine Database of German and German-Language Journals (CCMed) via LIVIVO (2000 to present)
10 October 2019
38 records
(((tax OR taxes OR taxation) AND (food OR sugar OR sweet OR sweets OR sweetened OR "fast food" OR snacks OR fat OR fats OR fatty OR "soL
drinks" OR "soL drink")) OR ((Steuer OR Steuern OR Besteuerung) AND (Essen OR Lebensmittel OR Zucker OR Süßigkeit OR Süßigkeiten OR
gesüßt OR Fastfood OR Snacks OR Fett OR Fette OR fetthaltig OR Süßgetränk OR Süßgetränke OR SoLdrink OR SoLdrinks))) DB=CCMED
Latin American and Caribbean Health Sciences (LILACS) via BIREME/VHL (1982 to present)
12 September 2019
95 records
tax or taxes or taxation or policy making [Words] and food or sugar or sweet or sweets or sweetened or fast food or snacks or fat or fats
or fatty or soL drinks [Words]
EconLit via EBSCO (1969 to present)
9 October 2019
4142 records
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S1. SU Taxes
S2. SU Government Programs
S3. SU Health Policy
S4. SU Health Promotion
S5. SU Nutrition Policy
S6. SU Public Health
S7. TX "demand elasticity"
S8. TX "policy intervention*"
S9. TX "sales tax"
S10. TX "thin subsidies"
S11. TX "vending machine*"
S12. TX budget
S13. TX excise
S14. TX fiscal
S15. TX levied
S16. TX levy
S17. TX price
S18. TX priced
S19. TX prices
S20. TX pricing
S21. TX subsidy
S22. TX subsidies
S23. TX tax
S24. TX taxation
S25. TX taxed
S26. TX taxes
S27. TX taxing
S28. S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19
OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27
S29. TX "chewing gum"
S30. TX "dietary sucrose"
S31. TX (("energy dens*" or "highenergy" or "high energy" or "high-energy" or "low energy" or chips) and (fat* or sugar* or sweet* or food
or diet* or nutrition or overweight or drink* or beverage* or protein* or carbohydrate*))
S32. TX "high calori* food*"
S33. TX "high-calori* food*"
S34. TX "low calori* food*"
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S35. TX "low-calori* food*"
S36. TX "ice cream*"
S37. TX "unhealthy food*"
S38. TX bakery
S39. TX biscuit*
S40. TX cacao
S41. TX cake*
S42. TX calorie*
S43. TX candy
S44. TX candies
S45. TX bonbon*
S46. TX chocolate*
S47. TX confectionar*
S48. TX cookie*
S49. TX isoglucose
S50. TX jam
S51. TX jelly
S52. TX jellies
S53. TX macronutrient*
S54. TX pastr*
S55. TX sucrose
S56. TX sugar
S57. TX sugars
S58. TX sugary
S59. TX sweet*
S60. SU Butter
S61. SU Fast Foods
S62. TX "fastfood*"
S63. TX "fast food*"
S64. TX "fast-food*"
S65. TX "fattening-food*"
S66. TX "fattening food*"
S67. TX "fried food*"
S68. TX "coconut oil"
S69. TX "cooking oil"
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S70. TX "palm oil"
S71. TX "vegetable oil"
S72. TX "soya oil"
S73. TX "soybean oil"
S74. TX "rapeseed oil"
S75. TX "linseed oil"
S76. TX "sunflower oil"
S77. TX "peanut oil"
S78. TX "groundnut oil"
S79. TX "olive oil"
S80. TX "salty-snack*"
S81. TX "salty snack*"
S82. TX "snack food*"
S83. TX "snack-food*"
S84. TX "take away food*"
S85. TX "take away-food*"
S86. TX "take-away food*"
S87. TX "take-away-food*"
S88. TX "whole milk"
S89. TX burger*
S90. TX butter
S91. TX cheese
S92. TX cream
S93. TX crisps
S94. TX egg
S95. TX eggs
S96. TX fat
S97. TX fatty
S98. TX fats
S99. TX fattening
S100. TX fries
S101. TX ghee
S102. TX lard
S103. TX margarine
S104. TX monounsat*
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S105. TX omega3
S106. TX "omega 3"
S107. TX omega-3
S108. TX pizza
S109. TX polyunsat*
S110. TX sausage*
S111. TX suet
S112. SU Carbonated Beverages
S113. SU Food Preferences
S114. TX Food Habits
S115. TX "carbonated-beverage
S116. TX "carbonated beverage*"
S117. TX "energy-drink*"
S118. TX "energy drink*"
S119. TX "high-calori* drink*"
S120. TX "high calori* drink*"
S121. TX "soda pop"
S122. TX "soL-drink*"
S123. TX "soL drink*"
S124. TX "sport* drink*"
S125. TX "sport*-drink*"
S126. TX cola
S127. TX soda
S128. TX SSB*
S129. TX syrup*
S130. S29 OR S30 OR S31 OR S32 OR S33 OR S34 OR S35 OR S36 OR S37 OR S38 OR S39 OR S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR
S46 OR S47 OR S48 OR S49 OR S50 OR S51 OR S52 OR S53 OR S54 OR S55 OR S56 OR S57 OR S58 OR S59 OR S60 OR S61 OR S62 OR S63 OR
S64 OR S65 OR S66 OR S67 OR S68 OR S69 OR S70 OR S71 OR S72 OR S73 OR S74 OR S75 OR S76 OR S77 OR S78 OR S79 OR S80 OR S81 OR
S82 OR S83 OR S84 OR S85 OR S86 OR S87 OR S88 OR S89 OR S90 OR S91 OR S92 OR S93 OR S94 OR S95 OR S96 OR S97 OR S98 OR S99 OR
S100 OR S101 OR S102 OR S103 OR S104 OR S105 OR S106 OR S107 OR S108 OR S109 OR S110 OR S111 OR S112 OR S113 OR S114 OR S115
OR S116 OR S117 OR S118 OR S119 OR S120 OR S121 OR S122 OR S123 OR S124 OR S125 OR S126 OR S127 OR S128 OR S129
S131. S28 AND S130
Campbell Library via Campbell Collaboration (2004 to present)
9 October 2019
23 records
'tax or taxes or taxation' IN All text and 'food* or sugar* or sweet or sweets or sweetened or fast food or snacks or fat or fats or fatty or
soL drinks' in All text
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Food Science and Technology Abstracts (FSTA) via OvidSP (1969 to present)
14 October 2019
1325 records
1 exp pricing/ or taxation/
2 ("tax" or "taxation" or "taxed" or "taxes" or "taxing" or "levy" or "levied").mp.
3 (("price" or "pricing" or "prices") adj2 "change?").mp.
4 (("price" or "pricing" or "prices") adj2 ("intervention?" or "experiment?")).mp.
5 ("sugar?" or "added food?" or "fat?" or "saturated" or "caloric" or "soL drink?" or "SSB?" or "sweetened beverage?" or "soL drink?" or
"carbonated drink?").mp.
6 or/1-4
7 5 and 6
Cumulative Index to Nursing and Allied Health Literature (CINAHL) via EBSCO (1937 to present)
12 September 2019
2792 records
S2 (MH "Government Programs+")
S3 (MH "Health Promotion+")
S4 (MH "Nutrition Policy+")
S5 TX "demand elasticity" OR TX "policy intervention*" OR TX "sales tax" OR TX "thin subsidies" OR TX "vending machine*" OR TX budget
OR TX excise OR TX fiscal OR TX levied OR TX levy OR TX price OR TX priced
S6 TX prices OR TX pricing OR TX subsidy OR TX subsidies OR TX tax OR TX taxation OR TX taxed OR TX taxes OR TX taxing
S7 S1 OR S2 OR S3 OR S4 OR S5 OR S6
S8 (MH "Dietary Carbohydrates+")
S9 (MH "Dietary Sucrose")
S10 (MM "High Fructose Corn Syrup")
S11 TX "chewing gum" OR TX ( (("energy dens*" or "highenergy" or "high energy" or "high-energy" or "low energy" or chips) and (fat* or
sugar* or sweet* or food or diet* or nutrition or overweight or drink* or beverage* or protein* or carbohydrate*)) ) OR TX "high calori*
food*" OR TX "high-calori* food*" OR TX "low calori* food*" OR TX "low-calori* food*" OR TX "ice cream*" OR TX "unhealthy food*" OR TX
bakery OR TX biscuit* OR TX cacao OR TX cake*
S12 TX calorie* OR TX candy OR TX bonbon* OR TX chocolate* OR TX confectionar* OR TX cookie* OR TX isoglucose OR TX jam OR TX jelly
OR TX jellies OR TX macronutrient* OR TX pastr*
S13 TX sucrose OR TX sugar OR TX sugars OR TX sugary OR TX sweet* OR TX Butter OR TX "fastfood*" OR TX "fast food*" OR TX "fast-food*"
OR TX "fattening-food*" OR TX "fattening food*" OR TX "fried food*"
S14 TX "coconut oil" OR TX "cooking oil" OR TX "palm oil" OR TX "vegetable oil" OR TX "soya oil" OR TX "soybean oil" OR TX "rapeseed oil"
OR TX "linseed oil" OR TX "sunflower oil" OR TX "peanut oil" OR TX "groundnut oil" OR TX "olive oil"
S15 TX "salty-snack*" OR TX "salty snack*" OR TX "snack food*" OR TX "snack-food*" OR TX "take away food" OR TX "take away-food*" OR
TX "take-away food" OR TX "take-away-food*" OR TX "whole milk" OR TX burger* OR TX cheese OR TX cream
S16 TX crisps OR TX ( (egg and (fat* or sugar* or sweet* or food or diet* or nutrition or overweight or drink* or beverage* or protein* or
carbohydrate*)) ) OR TX ( (eggs and (fat* or sugar* or sweet* or food or diet* or nutrition or overweight or drink* or beverage* or protein*
or carbohydrate*)) ) OR TX ( (fat and (Food* or diet* or nutrition or nutrient or eat* or meal* or oil* or carbohydrate* or protein* or obesity
or obese)) ) OR TX ( (fatty and (Food* or diet* or nutrition or nutrient or eat* or meal* or oil* or carbohydrate* or protein* or obesity or
obese)) ) OR TX fats OR TX fattening OR TX fries OR TX ghee OR TX lard OR TX margarine OR TX mono-unsat*
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S17 TX monounsat* OR TX omega3 OR TX "omega 3" OR TX omega-3 OR TX pizza OR TX polyunsat* OR TX sausage* OR TX suet
S18 (MM "Carbonated Beverages")
S19 (MM "Food Preferences")
S20 (MM "Food Habits")
S21 TX "caloric-drink*" OR TX "caloric drink*" OR TX "carbonated-beverage*" OR TX carbonated beverages OR TX "carbonated-drink*".
S22 TX "carbonated drink*" OR TX "energy-drink*" OR TX "energy drink*" OR TX "fizzy-drink*" OR TX "fizzy drink*" OR TX "high-calori*
drink*" OR TX "high calori* drink*" OR TX "soda pop" OR TX "soL-drink*" OR TX "soL drink*" OR TX "sport-drink*" OR TX "sport* drink*"
S23 TX "sport*-drink*" OR TX cola OR TX soda OR TX SSB* OR TX syrup*
S24 S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23
S25 S7 AND S24
S26 Restrict S25 to Academic Journals and Dissertations
Web of Science (SCI-EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-SSH, ESCI, CCR-EXPANDED, IC) via Clarivate Analytics (1900 to present)
12 September 2019
1364 records
TOPIC: (((("TAX" OR "TAXATION" OR "TAXED" OR "TAXES" OR "TAXING" OR "LEVY" OR "LEVIED") OR (("PRICE" OR "PRICING" OR "PRICES")
NEAR "CHANGE$") OR (("PRICE" OR "PRICING" OR "PRICES") NEAR ("INTERVENTION$" OR "EXPERIMENT$"))))) AND TOPIC: ((("SUGAR$"
OR "ADDED FOOD$" OR "FAT$" OR "SATURATED" OR "CALORIC" OR "SOFT DRINK$" OR "SSB$" OR "SWEETENED BEVERAGE$" OR "SOFT
DRINK$" OR "CARBONATED DRINK$")))
Timespan: All years. Indexes: SCI-EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-SSH, BKCI-S, BKCI-SSH, ESCI, CCR-EXPANDED, IC
Appendix 3. Search strategies for grey literature databases
ProQuest Dissertations & Theses Database (PQDT): UK and Ireland via ProQuest
9 September 2019
105 records
(ab(tax) OR ti(tax) OR ab(taxes) OR ti(taxes) OR ab(taxation) OR ti(taxation) ab(budget*) OR ti(budget*) OR ab(excise) or ti(excise)) AND
(ab(sugar*) OR ti(sugar*) OR ab(sweet*) OR ti(sweet*) OR ab("fast food*") OR ti("fast food*") OR ab(snack*) OR ti(snack*) OR ab(fat)
OR ti(fat) OR ab(fatty) OR ti(fatty) OR ab(fats) OR ti(fats) OR ab("soL drink*") OR ti("soL drink*") OR ab(beverage*) OR ti(beverage*) OR
ab(food*) OR ti(food*))
System for Information on Grey Literature in Europe – OpenGrey via OpenGrey
9 September 2019
33 records
((tax OR taxes OR taxation) AND (food OR sugar OR sweet OR sweets OR sweetened OR fast food OR snacks OR fat OR fats OR fatty OR "soL
drinks" OR "soL drink"))
The Directory of Open Access Repositories – OpenDOAR via OpenDOAR
12 December 2016 (database not accessible in subsequent searches)
71 records
(tax OR taxes OR taxation) AND (food OR sugar OR sweet OR sweets OR sweetened OR fast food OR snacks OR fat OR fats OR fatty OR "soL
drinks" OR "soL drink")
EconPapers via REPEC
14 October 2019
90 records
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(tax OR taxes OR taxation) AND (food OR sugar OR sweet OR sweets OR sweetened OR fast food OR snacks OR fat OR fats OR fatty OR "soL
drinks" OR "soL drink")
Social Science Research Network – SSRN eLibrary via SSRN
14 October 2019
168 records
"sugar tax" OR sweetened OR "Nutrient-Specific Taxes" OR "soda taxes" OR "food tax" OR "fat tax"
National Bureau of Economic Research (NBER) via NBER
13 October 2019
335 records
(tax OR taxes OR taxation) AND (food OR sugar OR sweet OR sweets OR sweetened OR fast food OR snacks OR fat OR fats OR fatty OR "soL
drinks" OR "soL drink")
WHO International Clinical Trials Registry Platform (WHO ICTRP) (includes references of the ClinicalTrials.gov database)
14 October 2019
164 records
(TITLE: tax or taxation or taxed or taxes or taxing or levy or levied or price or pricing or prices) OR (INTERVENTION: tax or taxation or taxed
or taxes or taxing or levy or levied or price or pricing or prices)
Trials Register of Promoting Health Interventions (TRoPHI) via EPPI-Centre
11 August 2016 (free text search not accessible in subsequent searches)
41 records
Freetext (All but Authors): "tax" or "taxation" or "taxed" or "taxes" or "taxing" or "levy" or "levied" or "price" or "pricing" or "prices"
Appendix 4. Search strategies for internet search engines
Google Scholar via Google
11 August 2016: 30 records
14 October 2019: 30 records
Total: 60 records
(tax OR taxes OR taxation) AND (food OR sugar OR sweet OR sweets OR sweetened OR fast food OR snacks OR fat OR fats OR fatty OR "soL
drinks" OR "soL drink")
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D I F F E R E N C E S   B E T W E E N   P R O T O C O L   A N D   R E V I E W
As reported in our protocol, we planned to plot the eIect direction, to analyze reporting bias (using funnel plots), perform meta-analysis,
and do subgroup and sensitivity analysis wherever possible. However, since insuIicient studies were eligible for inclusion, these methods
were not implemented. We did not undertake harvest plots for narrative synthesis. We further specified our eligibility criteria on types
of interventions. We excluded virtual and hypothetical interventions imitating a taxation on fat content of food if participants' purchase
decisions were not binding so that they did not all result in a real purchase, or if the money was virtual or not belonging to the study
participant.
We added text to the Methods section to clarify our definition of the overall risk of bias of included studies, and our criteria for appropriate
analysis of interrupted time series (ITS) studies.
We did not search the website from The Obesity Society (www.obesity.org), as it was not possible to enter the search terms. The database
from the website The Directory of Open Access Repositories – OpenDOAR, via OpenDOAR, was not accessible aLer the search on 12
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December 2016. The free-text search on the website Trials Register of Promoting Health Interventions (TRoPHI), via EPPI-Centre, was not
accessible aLer the search on 11 August 2016.
I N D E X   T E R M S
Medical Subject Headings (MeSH)
Commerce  [statistics & numerical data];  Denmark;  Dietary Fats  [*administration & dosage];  Interrupted Time Series Analysis;  Obesity
 [*prevention & control];  Overweight  [prevention & control];  *Taxes
MeSH check words
Adolescent; Adult; Child; Humans
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